[{"data":1,"prerenderedAt":2591},["ShallowReactive",2],{"content-site-settings":3,"site-map-pages-\u002Fsite-map":75,"site-map-solutions-\u002Fsite-map":639,"site-map-work-\u002Fsite-map":1043},{"id":4,"extension":5,"meta":6,"stem":73,"__hash__":74},"dataFiles\u002Fdata\u002Fsite.json","json",{"en":7},{"siteDetails":8,"siteLogo":11,"cookieControl":15,"mainNav":19,"footerContent":36,"preNav":41,"stickyNav":42,"solutionsMegaMenu":43},{"siteName":9,"siteUrl":10,"organisationName":9},"Morph","https:\u002F\u002Fmorph.co.uk",{"url":12,"alt":9,"width":13,"height":14},"morph-logo-2x.png",224,80,{"cookieModalTitle":16,"cookieModalText":17,"nonNecessaryCookiesUsed":18},"Cookies used on this site","This website only uses non-necessary cookies to remember where you are in the process and to learn about how people view the information. We do NOT use cookies that directly identify anyone. For the best experience please click Accept all below.",true,[20,23,26,29,32],{"title":21,"url":22},"Solutions","\u002Fsolutions",{"title":24,"url":25},"Work","\u002Fwork",{"title":27,"url":28},"About","\u002Fabout",{"title":30,"url":31},"More","\u002Fmore",{"target":33,"external":33,"title":34,"url":35},false,"Contact","\u002Fcontact",{"footerLogo":37,"footerCol1":38,"footerCol2":39,"footerCol3":40},{"url":12,"alt":9,"width":13,"height":14},"[Privacy policy](\u002Fprivacy)\\\n[Cookie policy](\u002Fcookie-policy)\\\n[Accessibility Statement](\u002Faccessibility)\\\n[Site map](\u002Fsite-map)[](\u002Fmorph-explainers)","**Address**\\\n8 New Shambles\\\nKendal\\\nLA9 4TS\n\n**Telephone** \\\n01524 884 288","**Email**\\\ninfo@morph.co.uk\n\n**Social**\\\n[YouTube](https:\u002F\u002Fwww.youtube.com\u002F@channelmorph)\\\n[LinkedIn](https:\u002F\u002Fuk.linkedin.com\u002Fcompany\u002Fmorphhq)[](https:\u002F\u002Fuk.linkedin.com\u002Fcompany\u002Fmorphhq)",[],[],[44,48,53,58,63,68],{"link":45,"summary":47},{"title":46,"url":22},"View all","Compare our clinical trial solutions or if you want a different approach get in touch.",{"link":49,"summary":52},{"title":50,"url":51},"Explainer","\u002Fsolutions\u002Fexplainer","Explain your study, patient information or results using 2D animation",{"link":54,"summary":57},{"title":55,"url":56},"Patient Info","\u002Fsolutions\u002Fpatient-info","Convert your PIS\u002FPIL into a patient information tool with supporting 2D animation",{"link":59,"summary":62},{"title":60,"url":61},"Study","\u002Fsolutions\u002Fstudy","Public-facing study website to support recruitment and patient understanding",{"link":64,"summary":67},{"title":65,"url":66},"Dissemination","\u002Fsolutions\u002Fdissemination","Share research results and outputs using a dedicated website and animation",{"link":69,"summary":72},{"title":70,"url":71},"Lifecycle","\u002Fsolutions\u002Flifecycle","Complete solution to support your study from recruitment through to results","data\u002Fsite","TO_fzpe1DjvIYgVPH74HjYP3TcgA7PkWivBqY-3snrM",[76,206,231,258,286,333,413,453,472,496,539],{"id":77,"title":27,"body":78,"description":78,"extension":5,"meta":79,"navigation":18,"path":202,"seo":203,"stem":204,"__hash__":205},"contentPages\u002Fpages\u002Fabout.en.json",null,{"pageTitle":27,"pageMetadata":80,"page_content":83,"pageSocialShare":200},{"htmlTitle":81,"htmlDesc":82},"About Morph | Clinical Trial Communication Experts","Founded in 2008, Morph specialises in clinical trial communication - creating animations and web tools that help participants and researchers.",[84,96,108,116,123,151,179],{"type":85,"sectionSettings":86,"settings":88,"title":90,"text":91,"image":92},"page_header",{"textAlign":87},"left",{"imgPosition":89},"bottom","# About","We've been helping our clients communicate since 2008.",{"url":93,"width":94,"height":95},"header-phone-hand-megafone-2x.png",1100,600,{"type":97,"sectionSettings":98,"settings":100,"text":104,"image":105},"text_and_image",{"textAlign":87,"sectionLabel":99},"Our story",{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103,"includeCTAs":33},"half-width","primary","vertical","## Our story\n\n**Morph was founded in 2008, when Tom Urry and Gareth Dennison moved in to The Storey building in Lancaster.**\n\nBefore that, we worked as freelancers across video, animation, and graphic design. We spent ten years based at The Storey before moving fully to our photo and video studio in Kendal in 2018, which we had set up in 2015. Around the time we fully moved to Kendal, Matthew Brook joined the business, bringing more than 15 years’ experience in health and social care software development.\n\nLike most people, we worked from home during the COVID period, before reassembling in our current base in the centre of Kendal. Throughout it all, we’ve deliberately maintained a small, talented team, working closely with the people we support.",{"url":106,"width":107,"height":107},"about-montage.png",500,{"type":97,"sectionSettings":109,"settings":111,"text":113,"image":114},{"textAlign":87,"sectionLabel":110},"Health research",{"imgWidth":101,"imgPosition":89,"textPosition":112,"btnTheme":102,"stackBtns":103,"includeCTAs":33},"right","## Health research\n\n**We’d worked on a handful of health research projects early on, but the real turning point came in 2016, when we became involved in the [TRECA](https:\u002F\u002Fmorph.co.uk\u002Ftreca) project at the University of York.**\n\nTRECA explored whether there were better ways of delivering patient information than the standard printed sheet. The project tested different approaches — including animation, video, and web — to see whether children and parents understood the information more clearly.\n\nThat work gave us a valuable introduction to clinical trials and the practical challenge of producing effective patient information. Through the contacts we made on TRECA, we began working on more trials, and this side of the business grew naturally from there. \n\nToday, almost all our work is in health research, with a strong focus on patient communication.",{"url":115,"width":107,"height":107},"about-content.png",{"type":97,"sectionSettings":117,"settings":119,"text":120,"image":121},{"textAlign":87,"sectionLabel":118},"Now and next",{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103,"includeCTAs":33},"## Now and next\n\n**Over the years, we’ve worked closely with trial teams, trial managers, technology experts, clinical researchers, and chief investigators.** \n\nWe’ve listened carefully, learned as we’ve gone, and paid attention to the common challenges. That experience shapes the work we do today. The Patient Information Tool grew out of our attempts to improve how patient information is delivered and used in real life.\n\nWe’ve now worked on upwards of 100 trials, and we use that experience to keep improving our solutions.\n\nWe’re interested in what’s coming next, and we’ll use new tools where they add something useful. Our focus is on making thoughtful improvements and building things that genuinely help.",{"url":122,"width":107,"height":107},"about-content-medical.png",{"type":124,"sectionSettings":125,"settings":128,"text":131,"cards":132},"text_and_cards",{"textAlign":126,"sectionLabel":127},"center","Meet the Team",{"alignCardContent":126,"showAllOnLoad":33,"categoriseWhenShowAll":33,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":129,"isFilterable":33,"headerFontSize":130,"alignCards":126},"3","4","## Meet the team",[133,141,146],{"type":134,"title":135,"summary":136,"image":137},"card_image_text","Tom Urry","Tom worked as a freelance camera operator and editor after spending many years travelling and working around the world. He later formed Morph with Gareth, who he met on a filmmaking course over twenty years ago. The third director, Matthew, is a friend from primary school. Tom helps guide the direction of the business and is often the first point of contact for new enquiries and client relationships.",{"url":138,"width":139,"height":140},"about-content-tom-2x.jpg",720,340,{"type":134,"title":142,"summary":143,"image":144},"Matthew Brook","Matthew is a software professional with over 20 years’ experience in health and social care IT. He joined Morph as a director in 2018 and leads on all things web-related, from early client conversations through to delivery and support. He also oversees contracts and finances. Matthew is particularly interested in improving processes and finding practical ways to use new technology to support efficient delivery.",{"url":145,"width":139,"height":140},"about-content-mattthew-2x.jpg",{"type":134,"title":147,"summary":148,"image":149},"Gareth Dennison","Gareth studied graphic design in Leeds and spent 10 years working commercially as an in-house designer. He later moved into freelance work, collaborating with Tom on a range of video and motion graphics projects before retraining in animation. Gareth co-founded Morph with Tom in 2008 and now leads the overall visual design and creative direction across all Morph projects.",{"url":150,"width":139,"height":140},"about-content-gareth-2x.jpg",{"type":124,"sectionSettings":152,"settings":154,"cards":157},{"textAlign":87,"sectionLabel":153},"Made with heart",{"alignCardContent":126,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":33,"headerLevel":129,"cardTheme":155,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":156,"alignCards":126},"transparent","5",[158,164,169,174],{"type":159,"icon":160,"summary":163,"title":153},"card_icon_text",{"iconSize":161,"iconName":162},"md","content-heart","We care about our work and put our hearts into making it the best it can be.",{"type":159,"icon":165,"summary":167,"title":168},{"iconSize":161,"iconName":166},"content-lightbulb","We want to work with brilliant clients who become our partners and grow with us.","Working with Morph",{"type":159,"icon":170,"summary":172,"title":173},{"iconSize":161,"iconName":171},"content-computer","We are always on the look out for great designers, developers and animators.","Working for Morph",{"type":159,"icon":175,"summary":177,"title":178},{"iconSize":161,"iconName":176},"content-thumbs-up","We make responsible choices about our people, our community and the environment.","Force for good",{"type":180,"sectionSettings":181,"slides":182},"morph_text_slider",{"textAlign":87},[183,190,195],{"narrowScreenImage":184,"wideScreenImage":187},{"url":185,"width":186,"height":95},"about-slider-mobile-2-2x.jpg",1200,{"url":188,"width":189,"height":95},"about-slider-desktop-2-2x.jpg",1920,{"narrowScreenImage":191,"wideScreenImage":193},{"url":192,"width":186,"height":95},"about-slider-mobile-2-copy-2x.jpg",{"url":194,"width":189,"height":95},"about-slider-desktop-1-copy-2x.jpg",{"narrowScreenImage":196,"wideScreenImage":198},{"url":197,"width":186,"height":95},"anout-slider-mobile-3-2x.jpg",{"url":199,"width":189,"height":95},"about-slider-desktop-3-2x.jpg",{"pageTitle":201,"pageDescription":201},"About Morph","\u002Fpages\u002Fabout.en",{"title":27},"pages\u002Fabout.en","Uxv7YLHRTtXOu92EwxLQ2nzxMPjsx7iMvpiHYFvXtMg",{"id":207,"title":208,"body":78,"description":78,"extension":5,"meta":209,"navigation":18,"path":227,"seo":228,"stem":229,"__hash__":230},"contentPages\u002Fpages\u002Faccessibility.en.json","Accessibility statement",{"pageTitle":208,"pageMetadata":210,"page_content":213,"page_strapline":225,"pageSocialShare":226},{"htmlTitle":211,"htmlDesc":212},"Our Accessibility Statement | Morph Media Ltd","Morph is committed to making our website accessible. Learn about our WCAG 2.2 Level AA compliance and how we've tested our site with assistive technologies.",[214,220],{"type":85,"title":215,"sectionSettings":216,"image":217,"settings":219},"# Accessibility statement",{"sectionLabel":208},{"url":218,"width":94,"height":95},"header-hand-magnifying-glass-study-site-2x.png",{"imgPosition":89},{"type":221,"text":222,"sectionSettings":223},"text","\\We are committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone, and applying the relevant accessibility standards.\n\n## Conformance status\n\nThe [Web Content Accessibility Guidelines (WCAG)](https:\u002F\u002Fwww.w3.org\u002FWAI\u002Fstandards-guidelines\u002Fwcag\u002F) defines requirements for designers and developers to improve accessibility for people with disabilities. It defines three levels of conformance: Level A, Level AA, and Level AAA. \\[TRIAL_NAME Participant Information] is partially conformant with WCAG 2.1 level AA. Partially conformant means that some parts of the content do not fully conform to the accessibility standard.\n\n### Specific exceptions to WCAG 2.1 level AA compliance\n\n* There is no site map or table of contents as the linear navigation path through the content (with no method for the user to jump ahead) mitigates against the usefulness of this feature.\n* Third party frameworks used to build this app - e.g.  [Nuxt](https:\u002F\u002Fnuxtjs.org\u002F) - may contain some minor accessibility issues which are not editable by Morph. This includes, for instance, CSS loading animations the duration of which has been to set to longer than 5 seconds. We have attempted to ensure that these exceptions do not impact negatively on user experience.\n* Colour contrast errors relating to the site footer navigation may be picked up by automated accessibility checking tools such as WAVE. These errors relate to the starting state of the effected elements prior to CSS animations occurring. Once the short loading animation is complete the visual appearance of the effected elements complies with WCAG AA colour contrast requirements.\n* We have not applied any customisation to focus indicators, instead relying on browser defaults. This approach allows any user applied customisation, e.g. through system-wide assistive technology, to be applied.\n\n## Screenreaders\n\nThis site has been tested in several screenreaders, including Narrator, NVDA and VoiceOver. We have striven to ensure that all content is accessible to these readers, although we are aware of inconsistencies in how they handle more complex features such as the video transcripts. Please [contact Morph](mailto:info@morph.co.uk) if you are unable to access any of the website content using your preferred screenreader.\n\n## Feedback\n\nWe welcome your feedback on the accessibility of this website. Please let us know if you encounter any accessibility barriers.",{"sectionLabel":224},"Conformance status","",{"pageTitle":208,"pageDescription":208},"\u002Fpages\u002Faccessibility.en",{"title":208},"pages\u002Faccessibility.en","_pB7BXJMpkEbMyC3WVpMkQr-bMMaDyFreaY2fEtazsc",{"id":232,"title":34,"body":78,"description":78,"extension":5,"meta":233,"navigation":18,"path":254,"seo":255,"stem":256,"__hash__":257},"contentPages\u002Fpages\u002Fcontact.en.json",{"pageTitle":34,"page_strapline":234,"pageMetadata":235,"page_content":238,"pageSocialShare":253},"A brand new page",{"htmlTitle":236,"htmlDesc":237},"Contact Morph | Clinical Trial Communication Enquiries","Get in touch with the Morph team to discuss your clinical trial communication needs - animations, patient information tools, study websites and more.",[239,247],{"type":85,"sectionSettings":240,"title":242,"text":243,"image":244,"settings":246},{"textAlign":87,"sectionLabel":241},"Contact Us","# Contact","Please get in touch to discuss your study or request a quote.",{"url":245,"width":94,"height":95},"header-character-laptop-wave-2x.png",{"imgPosition":89},{"type":248,"sectionSettings":249,"componentName":251,"text":252},"text_and_component",{"textAlign":87,"sectionLabel":250},"Contact form","StudyContactForm","## Contact form",{"pageTitle":34,"pageDescription":34},"\u002Fpages\u002Fcontact.en",{"title":34},"pages\u002Fcontact.en","3H3hVqi4UbT9MRgyYMUgpNU11K3t7zKMdtCvwJY5Zoc",{"id":259,"title":260,"body":78,"description":78,"extension":5,"meta":261,"navigation":18,"path":282,"seo":283,"stem":284,"__hash__":285},"contentPages\u002Fpages\u002Fcookie-policy.en.json","Cookie Policy",{"page_content":262,"pageMetadata":278,"pageTitle":260,"pageSocialShare":281},[263,269,273],{"type":85,"title":264,"sectionSettings":265,"image":266,"settings":268},"# Cookie Policy",{"sectionLabel":260},{"url":267,"width":94,"height":95},"hand-cookies-2x.png",{"imgPosition":89},{"type":221,"text":270,"sectionSettings":271},"## Website Cookies\n\nOur website uses necessary and non-necessary cookies. The necessary cookies are required for the website to function the right way, and they do not collect any of your personally identifiable data.\n\nThe non-necessary cookies used on our websites are used for understanding how the website is used so that we can provide you with a better user experience and help speed up your future interactions with our website.\n\n### Types of cookies we use\n\n**Necessary**: Some cookies are essential for you to be able to experience the full functionality of our site. They allow us to keep track of your progress through the site as well as enabling access to core functionality such as video playback. They do not collect or store any personal information.\n\n**Non-necessary**: These cookies store information like the number of visitors to the website, the number of unique visitors, which pages of the website have been visited, the source of the visit etc. These data help us understand and analyse how well the website performs and where it needs improvement.\n\n### Specific cookies we use\n\nThe cookies used in our website are shown below.\n\n#### Cookie Name: player \u002F vuid\n\n**Purpose**: When you press play Vimeo will drop third party cookies to enable the video to play and to collect analytics data such as how long a viewer has watched the video. These cookies do not track individuals.\n\n**Necessary**: yes\n\n**Expires in**: 1 year\n\n#### Cookie Name: _ga, _ga*\n\n**Purpose**: Used by Google Analytics to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. Stores information anonymously and assigns a randomly generated number to identify unique visitors.\n\n**Necessary**: no\n\n**Expires in**:  2 years\n\n#### Cookie Name: li_gc\n**Purpose:** Used by LinkedIn to store consent of guests regarding the use of cookies for non-essential purposes.\n\n**Necessary:** No\n\n**Expires in:** 6 months\n\n#### Cookie Name: bcookie\n\n**Purpose:** Used by LinkedIn's Insight Tag as a browser identifier cookie to track visitors across LinkedIn's services and measure the effectiveness of advertising campaigns.\n\n**Necessary:** No\n\n**Expires in:** 2 years\n\n#### Cookie Name: lidc\n\n**Purpose:** Used by LinkedIn to facilitate data center selection and track sharing of content across LinkedIn.\n\n**Necessary:** No\n\n**Expires in:** 24 hours\n\n#### Cookie Name: AnalyticsSyncHistory, lms_analytics\n\n**Purpose:** Used by LinkedIn's Insight Tag to track conversions, retarget visitors, and gather analytics about site visitors who interact with LinkedIn ads. Stores information to identify LinkedIn members and measure campaign performance.\n\n**Necessary:** No\n\n**Expires in:** 30 days\n\n\n## LocalStorage data\n\nWe also store data in your browser to keep track of your progress through the site and your cookie preferences. This is stored in [LocalStorage](https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FWeb_storage) and enables us to return you to the last page you visited in the site on subsequent visits. This data is anonymous, persistent and necessary for the functioning of the site.\n\n#### LocalStorage Key: GDPR:accepted\n\n**Purpose**: This localStorage property keeps track of whether you have accepted non-necessary cookies from this website. As no non-necessary cookies are used on this website it will default to true.\n\n**Necessary**: yes\n\n**Duration**: permanent\n\n#### LocalStorage Key: patient-info-vuex\n\n**Purpose**: This localStorage property keeps track of your progress through the site, enabling you to return to the last page you finished reading when you return to the site.\n\n**Necessary**: yes\n\n**Duration**: permanent\n\n## How can I control my cookie preferences?\n\nYou can edit your cookie preferences by clicking the link 'View and edit cookie settings' in the section 'What is my current cookie consent status?' below.\n\nIf you decide to 'Opt out' of non-necessary cookies, they may remain in your browser but will no longer be used to send data about your visit to the third party analytics service.\n\nIn addition to this, different browsers provide different methods to block and delete cookies used by websites. You can change the settings of your browser to block\u002Fdelete the cookies. To find out more out more on how to manage and delete cookies, visit [wikipedia.org](https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FHTTP_cookie), [www.allaboutcookies.org.](http:\u002F\u002Fwww.allaboutcookies.org\u002F)\n\n## Contact Us\n\nIf you have any questions about the content of this page or problems with the website, please contact us at: admin@morph.co.uk",{"sectionLabel":272},"Website Cookies",{"type":248,"text":274,"componentName":275,"sectionSettings":276},"## What is my current cookie consent status?","CookiesOptInOut",{"sectionLabel":277},"View and Edit Cookie Settings",{"htmlTitle":279,"htmlDesc":280},"Our Cookie & Tracking Policy | Morph Media Ltd","Information about the cookies and tracking technologies used on the Morph website, including Google Analytics, LinkedIn Insight Tag, and Vimeo.",{"pageTitle":260,"pageDescription":260},"\u002Fpages\u002Fcookie-policy.en",{"title":260},"pages\u002Fcookie-policy.en","gkjFYDPHjVUTP71Y3Q6uYKIMvvIpsZWL9pi-dD_ykZM",{"id":287,"title":288,"body":78,"description":78,"extension":5,"meta":289,"navigation":18,"path":329,"seo":330,"stem":331,"__hash__":332},"contentPages\u002Fpages\u002Ffaqs.en.json","FAQS",{"pageTitle":290,"pageMetadata":291,"page_content":294},"FAQs",{"htmlTitle":292,"htmlDesc":293},"Answers to Frequently Asked Questions | Morph","Answers to common questions about working with Morph on clinical trial animations, patient information tools, study websites, and the project process.",[295,302,316],{"type":85,"sectionSettings":296,"settings":297,"title":298,"text":299,"image":300},{"textAlign":87},{"imgPosition":89},"# FAQs","Nam nisl est, mattis sed risus eget, pharetra suscipit tortor. Cras vel urna scelerisque, aliquet eros id, commodo urn",{"url":301,"width":94,"height":95},"morph-header-image 1@2x.png",{"type":303,"sectionSettings":304,"settings":305,"accordionItems":306},"text_and_accordion",{"textAlign":87},{"accordionHeaderLevel":129,"accordionHeaderFontSize":156,"accordionTheme":102,"accordionItemsCollapsed":18},[307,311],{"icon":308,"title":309,"content":310},{"iconSize":78,"iconTheme":78},"Logos and branding","Quisque nec fermentum libero, in iaculis lacus. Proin id magna ut tortor elementum auctor ut eu turpis. Fusce molestie cursus nisl ut volutpat.",{"icon":312,"title":314,"content":315},{"iconSize":313,"iconTheme":102},"lg","Change orders","Curabitur libero lacus, laoreet a pretium vitae, vestibulum ut orci. Proin molestie, arcu eget euismod placerat, dolor justo congue lorem, eleifend luctus urna nunc quis justo. \n\nNam ultrices ac ligula non dignissim. Mauris sodales consectetur eros, quis porta eros ullamcorper at.",{"type":97,"sectionSettings":317,"settings":318,"title":319,"text":320,"image":321,"links":325},{"textAlign":87},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"## Still have questions?","Donec facilisis euismod ullamcorper. Integer luctus ex turpis. Praesent velit turpis, maximus sed ullamcorper et, pellentesque a sapien. Mauris sit amet augue ut tellus semper porttitor. Sed elementum tincidunt justo. Curabitur sollicitudin nisl sed commodo sagittis. Vivamus tristique lacus est, placerat congue risus semper in. Praesent facilisis dictum est sed dapibus. Fusce a velit non libero gravida dictum. Morbi rhoncus velit massa, eget eleifend quam tristique et. Proin viverra ligula nec risus ultrices vehicula.",{"url":322,"width":323,"height":324},"morph-content-image 4@2x.png",910,520,[326],{"icon":327,"iconPosition":112,"link":328},{"iconSize":313,"iconTheme":102},{"title":241,"url":35},"\u002Fpages\u002Ffaqs.en",{"title":288},"pages\u002Ffaqs.en","ku8UHU1t0Xvkpv978NXOLHH55PUEmCzUSTBFY26Uxjk",{"id":334,"title":335,"body":78,"description":78,"extension":5,"meta":336,"navigation":18,"path":409,"seo":410,"stem":411,"__hash__":412},"contentPages\u002Fpages\u002Findex.en.json","Home page",{"pageTitle":337,"pageMetadata":338,"page_content":341,"pageSocialShare":406},"Clinical trial communication",{"htmlTitle":339,"htmlDesc":340},"Clinical Trial Communication Specialists | Morph","Morph creates animations and digital tools that help patients understand clinical trials - from recruitment to results. Over 100 trials supported since 2008.",[342,352,354,359,362,364,404],{"settings":343,"sectionSettings":344,"text":346,"strapline":225,"title":347,"links":348,"type":85,"image":349},{"imgPosition":89},{"sectionLabel":345,"customClass":225},"Home page header","We create explainer animations and web tools that help people understand research.","# Clinical trial communication",[],{"url":350,"width":351,"height":95},"header-character-explainers-2x.png",1000,{"type":353},"morph_logos_section",{"type":355,"sectionSettings":356,"textCol2":357,"textCol1":358},"text_two_cols",{"textAlign":87},"Each solution is tailored to the study’s design, population, and language requirements.\n\nFor studies requiring a different approach, we offer flexible creative and technical options.\n\nOur experience in clinical trial communication means we understand the aims, the process and the challenges.","We provide five core solutions to support your study from recruitment to dissemination.",{"type":360,"text":361},"morph_solutions","## Morph Solutions",{"type":363},"morph_features_section",{"type":124,"sectionSettings":365,"settings":368,"text":369,"cards":370},{"textAlign":126,"sectionLabel":366,"customClass":367},"Test WORK cards","work-cards-section",{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},"## Our Work",[371,380,388,396],{"type":134,"imgPosition":89,"strapline":372,"title":373,"summary":225,"image":374,"link":377,"categories":379},"University of Oxford","RECOVERY Trial",{"url":375,"width":139,"height":376},"morph-work-card-image 10@2x.png",460,{"url":378},"\u002Fwork\u002Frecovery-trial",[50],{"type":134,"imgPosition":89,"strapline":381,"title":382,"image":383,"link":385,"categories":387},"University of Birmingham","ELSA Study",{"url":384,"width":139,"height":376},"morph-work-card-elsa-2x.png",{"url":386},"\u002Fwork\u002Felsa-study",[50,60,55],{"type":134,"imgPosition":89,"strapline":389,"title":390,"image":391,"link":393,"categories":395},"University of Liverpool","C-GULL Study",{"url":392,"width":139,"height":376},"morph-work-card-c-gull-2x.png",{"url":394},"\u002Fwork\u002Fc-gull-study",[60,50,55],{"type":134,"imgPosition":89,"strapline":397,"title":398,"image":399,"link":401,"categories":403},"University of Cambridge","Healthy Start, Happy Start ",{"url":400,"width":139,"height":376},"morph-work-card-healthy-start-2x.png",{"url":402},"\u002Fwork\u002Fhealthy-start-happy-start",[65,50],{"type":405},"morph_next_steps",{"pageTitle":407,"pageDescription":408},"Research communication","Digital tools for health research communication","\u002Fpages\u002Findex.en",{"title":335},"pages\u002Findex.en","ZPfMyr40h3bMyae8m7spuIJrQQjMFNPCHY-uLHNBI20",{"id":414,"title":30,"body":78,"description":78,"extension":5,"meta":415,"navigation":18,"path":449,"seo":450,"stem":451,"__hash__":452},"contentPages\u002Fpages\u002Fmore.en.json",{"pageTitle":30,"pageMetadata":416,"pageSocialShare":419,"page_content":420},{"htmlTitle":417,"htmlDesc":418},"More from Morph | Clinical Trial Resources...","Explore more from Morph — access free clinical trial explainer animations and find out about our involvement in the TRECA Study, where it all began.",{"pageTitle":30,"pageDescription":30},[421,429],{"settings":422,"sectionSettings":423,"text":425,"strapline":225,"title":426,"links":427,"type":85,"image":428},{"imgPosition":89},{"sectionLabel":424,"customClass":225},"More... page header","Discover more about Morph's work in clinical trial communication, including our free Explainer Animations.","# More...",[],{"url":301,"width":351,"height":95},{"type":124,"sectionSettings":430,"settings":431,"cards":433,"text":225},{"textAlign":126},{"alignCardContent":126,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":33,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":432,"isFilterable":33,"headerFontSize":129,"alignCards":126},"2",[434,442],{"type":134,"imgPosition":435,"title":436,"image":437,"summary":439,"link":440},"top","Morph Explainers",{"url":438},"2card-patient-info-2-2x.png","These free animations explain key information about clinical research.",{"url":441},"\u002Fmorph-explainers",{"type":134,"imgPosition":435,"title":443,"summary":444,"image":445,"link":447},"The TRECA Study","The starting point for our work in clinical trial communication.",{"url":446},"treca-card-2x.png",{"url":448},"\u002Ftreca","\u002Fpages\u002Fmore.en",{"title":30},"pages\u002Fmore.en","qreHuHwBaF4F8Dqlt-xYKiFTH9TSvAGHaweNnPkROgs",{"id":454,"title":455,"body":78,"description":78,"extension":5,"meta":456,"navigation":18,"path":468,"seo":469,"stem":470,"__hash__":471},"contentPages\u002Fpages\u002Fmorph-explainers.en.json","Morph explainers",{"pageTitle":455,"pageMetadata":457,"pageSocialShare":460,"page_content":461},{"htmlTitle":458,"htmlDesc":459},"Free Clinical Research Explainer Animations | Morph","Free animations explaining key concepts in clinical research - designed for patients, participants, and the public. Available for adults and children.",{"pageTitle":455,"pageDescription":455},[462],{"type":85,"sectionSettings":463,"settings":464,"title":465,"text":466,"image":467},{"textAlign":87},{"imgPosition":89},"# Morph explainers","**These free animations explain key information about clinical research.**",{"url":350,"width":351,"height":95},"\u002Fpages\u002Fmorph-explainers.en",{"title":455},"pages\u002Fmorph-explainers.en","8vkNgdwfNdabitgzeQOvTYIcOB-Y1nOSOEIwJ_44Vzo",{"id":473,"title":474,"body":78,"description":78,"extension":5,"meta":475,"navigation":18,"path":492,"seo":493,"stem":494,"__hash__":495},"contentPages\u002Fpages\u002Fprivacy.en.json","Privacy policy",{"pageMetadata":476,"page_content":479,"pageTitle":490,"pageSocialShare":491},{"htmlTitle":477,"htmlDesc":478},"Privacy Policy | Morph Clinical Trial Communication","How Morph collects, uses and protects your personal data. We store minimal information and do not share your data with third parties without consent.",[480,486],{"type":85,"title":481,"sectionSettings":482,"image":483,"strapline":474,"settings":485},"# Privacy policy",{"sectionLabel":474},{"url":484,"width":94,"height":95},"header-character-child-ipad-2x.png",{"imgPosition":435},{"type":221,"text":487,"sectionSettings":488},"This website has been designed and developed by Morph specifically for this clinical trial. We understand that your privacy is important to you and that you care about how your personal data is used. We respect and value the privacy of all of our customers and suppliers’ data and will only collect and use personal data in ways that are described here, and in a way that is consistent with our obligations and your rights under the law.\n\n## 1. Information about us\n\nMorph is a partnership.\n\nMain trading address: 8 New Shambles, Kendal, LA9 4TS\n\nVAT Reg: 400693620\n\nData Protection Officer: Matthew Brook\n\nEmail address: info@morph.co.uk\n\nTelephone number: 01524 884 288\n\nPostal Address: 8 New Shambles, Kendal, LA9 4TS\n\n## 2. What does this policy cover?\n\nThis Privacy Policy relates specially to this website only and explains how we use your personal data on the site: how it is collected, how it is held, and how it is processed. It also explains your rights under the law relating to your personal data.\n\n## 3. What is personal data?\n\nPersonal data is defined by the General Data Protection Regulation (EU Regulation 2016\u002F679) (the “GDPR”) as ‘any information relating to an identifiable person who can be directly or indirectly identified in particular by reference to an identifier’. Personal data is, in simpler terms, any information about you that enables you to be identified. Personal data covers obvious information such as your name and contact details, but it also covers less obvious information such as identification numbers, electronic location data, and other online identifiers. The personal data that we use is set out in Part 5, below.\n\n## 4. What are your rights?\n\nUnder the GDPR, you have the following rights, which we will always work to uphold:\n\n1. The right to be informed about our collection and use of your personal data. This Privacy Policy should tell you everything you need to know, but you can always contact us to find out more or to ask any questions using the details in Part 11.\n2. The right to access the personal data we hold about you. Part 10 will tell you how to do this.\n3. The right to have your personal data rectified if any of your personal data held by us is inaccurate or incomplete. Please contact us using the details in Part 11 to find out more.\n4. The right to be forgotten, i.e. the right to ask us to delete or otherwise dispose of any of your personal data that we have. Please contact us using the details in Part 11 to find out more.\n5. The right to restrict (i.e. prevent) the processing of your personal data.\n6. The right to object to us using your personal data for a particular purpose or purposes.\n7. The right to data portability. This means that, if you have provided personal data to us directly, we are using it with your consent or for the performance of a contract, and that data is processed using automated means, you can ask us for a copy of that personal data to re-use with another service or business in many cases.\n8. Rights relating to automated decision-making and profiling. We do not use your personal data in this way.\n\nFor more information about our use of your personal data or exercising your rights as outlined above, please contact us using the details provided in Part 11.\n\nFurther information about your rights can also be obtained from the Information Commissioner’s Office or your local Citizens Advice Bureau.\n\nIf you have any cause for complaint about our use of your personal data, you have the right to lodge a complaint with the Information Commissioner’s Office.\n\n## 5. What personal data do we collect when you visit this website?\n\nYou may visit the Site without telling us who you are or revealing any personally identifiable information about you. The website is hosted by Netlify and their servers log the IP addresses of all requests for security purposes. These logs are stored for less than 30 days and are not used to identify individuals. \n\nNetlify is committed to helping users understand the General Data Protection Regulation and to comply with its requirements and Morph have entered into a legally binding Data Protection Agreement with Netlify to ensure that this is the case (https:\u002F\u002Fwww.netlify.com\u002Fgdpr-ccpa)\n\n[Cookie Policy](\u002Fcookie-policy)\n\n## 6. How do we use your personal data?\n\nUnder the GDPR, we must always have a lawful basis for using personal data. This may be because the data is necessary for our performance of a contract with you, because you have consented to our use of your personal data, or because it is in our legitimate business interests to use it. Your personal data may be used for one of the following purposes:\n\n* IP addresses are required by Netlify to troubleshoot a number of issues, such as connectivity issues, tracking down specific HTTP responses, tracking DDoS attacks.\n\n## 7. How long will we keep your personal data?\n\nIP addresses are logged for no more than 30 days.\n\n## 8. How and where do we store or transfer your personal data?\n\nWe may store or transfer some or all of your personal data in countries that are not part of the European Economic Area (the “EEA” consists of all EU member states, plus Norway, Iceland, and Liechtenstein). These are known as “third countries” and may not have data protection laws that are as strong as those in the UK and\u002For the EEA. Morph have signed a Data Protection Agreement with Netlify to ensure that your personal data is treated just as safely and securely as it would be within the UK and under the GDPR.\n\n## 9. Do we share your personal data?\n\nNo.\n\n## 10. How can I access my personal data?\n\nMorph do not have access to IP addresses logged by Netlify.\n\n## 11. How do I contact you?\n\nTo contact us about anything to do with your personal data and data protection, including to make a subject access request, please use the following details (for the attention of Matthew Brook):\n\nEmail address: info@morph.co.uk\n\nTelephone number: 01524 884 288\n\nPostal Address: 8 New Shambles, Kendal, LA9 4TS\n\nPursuant to Article 27 of the European Union (EU) and United Kingdom (UK) General Data Protection Regulation, VeraSafe has been appointed as Netlify’s representative in the European Union and United Kingdom for data protection matters. VeraSafe can be contacted in addition to [privacy@netlify.com](mailto:privacy@netlify.com), only on matters related to the processing of personal data.\n\nTo make such an inquiry, please contact VeraSafe using this [contact form](https:\u002F\u002Fverasafe.com\u002Fpublic-resources\u002Fcontact-data-protection-representative) or via telephone at: +44 (20) 4532 2003. Alternatively, VeraSafe can be contacted at:\n\n**VeraSafe United Kingdom Ltd.**\\\n37 Albert Embankment London SE1 7TL\\\nUnited Kingdom\n\n## 12. Changes to this Privacy Policy\n\nWe may change this Privacy Policy from time to time. This may be necessary, for example, if the law changes, or if we change our business in a way that affects personal data protection. Any changes will be made available on this website.",{"sectionLabel":489},"Privacy page details","Privacy page",{"pageTitle":474,"pageDescription":474},"\u002Fpages\u002Fprivacy.en",{"title":474},"pages\u002Fprivacy.en","ga_-AXKWTvzFZxSV3kTtlUifvAQj4WUa_PciS6NBZ_s",{"id":497,"title":498,"body":78,"description":78,"extension":5,"meta":499,"navigation":18,"path":535,"seo":536,"stem":537,"__hash__":538},"contentPages\u002Fpages\u002Fprocess.en.json","Process",{"pageTitle":498,"pageMetadata":500,"page_content":503,"pageSocialShare":534},{"htmlTitle":501,"htmlDesc":502},"Our Clinical Trial Communication Process | Morph","Morph's four-stage project process: pre-planning, design and scripting, animation and build, and delivery - tailored for clinical trial communication projects.",[504,511,517,523,528,533],{"type":85,"sectionSettings":505,"settings":506,"title":507,"text":508,"image":509},{"textAlign":87},{"imgPosition":89},"# Process","Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do et dolore magna aliqua.",{"url":510,"width":94,"height":95},"header-hand-process-2x.png",{"type":97,"sectionSettings":512,"settings":513,"text":514,"image":515},{"textAlign":87},{"imgWidth":101,"imgPosition":89,"textPosition":87},"## \u003Cspan class=\"text-secondary\">1\u003C\u002Fspan> Pre-planning\n\nLorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce eu libero sed dui tempor dapibus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Pellentesque est erat, tempus et laoreet nec, tincidunt a dolor. In pharetra feugiat libero, in tempor justo elementum vel.",{"url":516,"width":323,"height":324},"content-hands-phone-process-2x.png",{"type":97,"sectionSettings":518,"settings":519,"text":520,"image":521},{"textAlign":87},{"imgWidth":101,"imgPosition":89,"textPosition":87},"## \u003Cspan class=\"text-secondary\">2\u003C\u002Fspan> Design and scripting\n\nPellentesque dignissim maximus viverra. Phasellus ullamcorper sodales ex, id ullamcorper purus commodo quis. Mauris faucibus lorem vel orci commodo, eu porttitor dui finibus. Ut nec placerat risus. Suspendisse ut tellus nisl. Nam vel sem scelerisque, congue libero at, cursus ligula. Aliquam dolor magna, porta a aliquam eu, laoreet non augue. Nam ut leo mi. Mauris lectus eros, pretium eget consequat et, tincidunt ac odio. Duis nec rutrum justo.",{"url":522,"width":323,"height":324},"morph-content-image 3@2x.png",{"type":97,"sectionSettings":524,"settings":525,"text":526,"image":527},{"textAlign":87},{"imgWidth":101,"imgPosition":89,"textPosition":87},"## \u003Cspan class=\"text-secondary\">3\u003C\u002Fspan> Animation and build\n\nPhasellus mi est, pharetra eget enim eget, interdum hendrerit dolor. Aliquam id diam porttitor, egestas ex eu, facilisis tortor. Nullam iaculis porta efficitur. Etiam vitae libero sed ipsum lacinia eleifend. Vivamus eu consectetur nisi. Fusce a gravida lectus. Phasellus gravida suscipit lorem, non scelerisque erat convallis vel. \n\nVivamus varius eros vel odio sodales suscipit ut et diam. Suspendisse pulvinar magna sit amet molestie ultrices. Integer neque neque, consectetur eu lacinia ut, sagittis vitae dolor. Cras mattis massa quis est faucibus venenatis. Maecenas non mauris felis. Sed volutpat dapibus libero. Aliquam vitae placerat tellus. Pellentesque a lobortis ex. Phasellus nec nibh at orci pellentesque pellentesque ut sit amet turpis.",{"url":522,"width":323,"height":324},{"type":97,"sectionSettings":529,"settings":530,"text":531,"image":532},{"textAlign":87},{"imgWidth":101,"imgPosition":89,"textPosition":87},"## \u003Cspan class=\"text-secondary\">4\u003C\u002Fspan> Delivery\n\nInteger risus nulla, viverra malesuada eleifend vel, vulputate a enim. Ut non sagittis arcu. Nulla venenatis sem sit amet tempus suscipit. Nam feugiat pellentesque est quis bibendum. Mauris efficitur interdum tellus, nec sollicitudin lacus vestibulum nec. Etiam lacus erat, luctus nec pretium eu, ornare sed enim. Suspendisse potenti. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Morbi blandit nunc tempus, finibus lorem vel, sagittis nibh.",{"url":322,"width":323,"height":324},{"type":405},{"pageTitle":498,"pageDescription":498},"\u002Fpages\u002Fprocess.en",{"title":498},"pages\u002Fprocess.en","7m7REacuhtPv6a4wleR5_GZ7kZ2zSTtc7ikQVCaUyfE",{"id":540,"title":541,"body":78,"description":78,"extension":5,"meta":542,"navigation":18,"path":635,"seo":636,"stem":637,"__hash__":638},"contentPages\u002Fpages\u002Ftreca.en.json","TRECA Study",{"pageTitle":541,"pageMetadata":543,"page_content":546,"pageSocialShare":634},{"htmlTitle":544,"htmlDesc":545},"TRECA Study | Clinical Trial Communication Research | Morph","NIHR-funded TRECA programme evaluated multimedia participant information in 6 paediatric NHS clinical trials. Morph created animations and digital tools.",[547,555,562,569,576,583,591,620,627],{"type":85,"sectionSettings":548,"settings":549,"title":550,"text":551,"image":552,"strapline":554},{"textAlign":87},{"imgPosition":89},"# The TRECA Study","Improving participant information for children and young people in clinical trials.",{"url":553,"width":94,"height":95},"treca-header-2x.png","University of York",{"type":97,"sectionSettings":556,"settings":558,"text":559,"image":560},{"textAlign":87,"sectionLabel":557},"TRECA ",{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103,"includeCTAs":33},"## The background\n\n**Morph worked with the University of York and NHS research teams on the NIHR-funded TRECA programme.** TRECA explored whether multimedia participant information could help children, young people and families better understand clinical trials and support decision-making about taking part in research.\n\nThe programme evaluated multimedia information within six NHS clinical trials across a range of clinical settings including cancer care, orthopaedics, ophthalmology, emergency medicine and cardiac surgery.\n\nMorph designed and produced the multimedia participant information used throughout the programme, including animations, participant information websites and video content adapted for different studies and age groups.",{"url":561,"width":107,"height":107},"treca-content-1-2x.png",{"type":97,"sectionSettings":563,"settings":565,"text":566,"image":567},{"textAlign":87,"sectionLabel":564},"The challenge",{"imgWidth":101,"imgPosition":89,"textPosition":112,"btnTheme":102,"stackBtns":103,"includeCTAs":33},"## The challenge\n\n**Participant information sheets are an important part of clinical research, but they are often long, technical and difficult to understand.**\n\nChildren, young people and families are sometimes asked to consider research participation while managing unfamiliar medical information and stressful clinical situations.\n\nTRECA explored whether multimedia information could provide a clearer and more accessible way to explain clinical trials and research participation.",{"url":568,"width":107,"height":107},"treca-content-2-2x.png",{"type":97,"sectionSettings":570,"settings":572,"text":573,"image":574},{"textAlign":87,"sectionLabel":571},"What was TRECA?",{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103,"includeCTAs":33},"## What was TRECA?\n\n**TRECA, which stands for *TRials Engagement in Children and Adolescents*, was a research programme led by Professor Peter Knapp at the University of York and funded by the National Institute for Health and Care Research (NIHR).**\n\nThe programme explored how multimedia information could support recruitment and informed decision-making in paediatric clinical trials.\n\nRather than evaluating multimedia information separately, TRECA embedded the approach within six active NHS clinical trials. This allowed researchers to evaluate multimedia participant information in real clinical settings with children, young people and families considering participation in genuine research studies.\n\nThe programme also involved a co-design process with children, young people, parents and healthcare professionals to help shape the structure and presentation of the multimedia information resources.",{"url":575,"width":107,"height":107},"treca-content-3-2x.png",{"type":97,"sectionSettings":577,"settings":579,"image":580,"text":582},{"textAlign":87,"sectionLabel":578},"Morph’s role",{"imgWidth":101,"imgPosition":89,"textPosition":112,"btnTheme":102,"stackBtns":103,"includeCTAs":33},{"url":581,"width":107,"height":107},"treca-content-4-2x.png","## Morph’s role\n\n**Morph worked closely with researchers, clinicians and trial teams to design and produce the multimedia participant information used throughout the programme.**\n\nAcross the six studies, Morph developed:\n\n* Participant information websites\n* Animated study explainers\n* Talking head videos\n* Age-adapted information pathways\n* Mobile-friendly digital delivery\n* Visual explanations of treatments and study processes\n\nThe multimedia resources included both trial-specific content and reusable animations explaining wider concepts such as informed consent, randomisation and clinical trials.\n\nThe content was designed to make complex research information easier to understand while remaining balanced, accurate and suitable for children, young people and families.\n\nEach study required a different approach depending on the clinical setting, participant age group and complexity of the research.",{"type":584,"sectionSettings":585,"settings":587,"video":588},"text_and_video",{"textAlign":87,"sectionLabel":586},"BAMP Study Animation",{"videoPosition":89,"videoAlign":87},{"vimeoId":589,"videoTitle":586,"videoTranscript":590},"245943640?h=da82f3c36a","\n\nThe BAMP trial wants to find the best treatment for 11 to 14 year olds who have a reverse bite.\n\nA reverse bite means your top jaw and teeth are further back in your mouth than your bottom teeth.\n\nBraces alone cannot correct this.\n\nPeople usually have to wait until they are 17 for a jaw operation to fix it.\n\nA new operation is now available in the UK for people aged 11 to 14.\n\nWe want to see how well it moves the top jaw forward.\n\nThis operation has been used in Belgium for 10 years.\n\nWe also want to see if having this operation now means you will not need jaw surgery at 17.\n\nIn the trial, half the people will have the BAMP operation and the other half will not.\n\nYou cannot choose which group you are in.\n\nThis is to make the trial fair. The groups are decided by chance.\n\nWe can then compare the results of having the BAMP operation with not having it.\n\nIf you do not have the BAMP operation now, you will still be offered jaw surgery when you are 17.",{"type":303,"sectionSettings":592,"settings":593,"accordionItems":594,"text":619},{"textAlign":87},{"accordionHeaderLevel":129,"accordionHeaderFontSize":156,"accordionTheme":102,"accordionItemsCollapsed":18,"accordionSingleOpenItem":18,"accordionScrollToTopOnOpen":18},[595,599,603,607,611,615],{"icon":596,"title":597,"content":598},{"iconSize":313},"UKALL 2011","**University of Birmingham**\n\nA paediatric cancer study involving children and young people with acute lymphoblastic leukaemia. Multimedia information was developed to help explain treatment pathways and study participation to different age groups.",{"icon":600,"title":601,"content":602},{"iconSize":313},"CHAMP","**Belfast Health and Social Care Trust**\n\nA study investigating treatments for childhood glaucoma. Multimedia participant information was developed to help explain long-term treatment and study participation to children and families.",{"icon":604,"title":605,"content":606},{"iconSize":313},"BAMP","**University Hospital of South Manchester**\n\nAn orthodontic research study involving treatment using a bonded maxillary expansion appliance. Multimedia information was also evaluated as part of research exploring understanding and decision-making during trial recruitment.",{"icon":608,"title":609,"content":610},{"iconSize":313},"Thermic-3","**University of Bristol**\n\nA cardiac surgery study comparing different temperature management approaches during surgery. Multimedia content was developed to help explain complex surgical research information in a more accessible way.",{"icon":612,"title":613,"content":614},{"iconSize":313},"FORCE","**University of Oxford** \n\nA study involving treatment for wrist fractures in children. Participant information was designed to support understanding during recruitment in busy emergency department settings.",{"icon":616,"title":617,"content":618},{"iconSize":313},"BALANCE","**University of York**\n\nA study exploring treatments for amblyopia in children. Multimedia information was developed to help explain treatment pathways and research participation to children and families.","## Embedded trials",{"type":97,"sectionSettings":621,"settings":623,"text":624,"image":625},{"textAlign":87,"sectionLabel":622},"Research findings",{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103,"includeCTAs":33},"## Research findings\n\n**TRECA evaluated whether multimedia participant information could improve recruitment and support decision-making compared with standard printed participant information sheets.**\n\nThe programme involved six Studies Within A Trial (SWATs), where participants were randomly allocated to receive either multimedia information, printed information sheets, or a combination of both.\n\nPublished findings showed that children and young people who received multimedia information alone were more likely to be recruited into trials than those receiving printed information sheets alone.\n\nResearch linked to the programme also found that multimedia information was viewed positively by children, young people and families and could support understanding and confidence during decision-making about research participation.",{"url":626,"width":107,"height":107},"treca-content-7-2x.png",{"type":97,"sectionSettings":628,"settings":630,"text":631,"image":632},{"textAlign":87,"sectionLabel":629},"Research links",{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103,"includeCTAs":33},"## Related links\n\n**University of York**\n\n[THE TRECA STUDY:  Trials engagement in children and adolescents](https:\u002F\u002Fwww.york.ac.uk\u002Fhealthsciences\u002Fresearch\u002Fhealth-policy\u002Fresearch\u002Fdecision-making-projects\u002Ftrials-engagement-in-children\u002F)\n\n**Sage Journals**\n\n[Evaluating the use of multimedia information when recruiting adolescents to orthodontics research: A randomised controlled trial](https:\u002F\u002Fjournals.sagepub.com\u002Fdoi\u002Ffull\u002F10.1177\u002F14653125211024250)\n\n**NIHR Journals Library**\n\n[The effectiveness and acceptability of multimedia information when recruiting children and young people to trials: the TRECA meta-analysis of SWATs](https:\u002F\u002Fwww.journalslibrary.nihr.ac.uk\u002Fhsdr\u002FHTPM3841?utm_source=chatgpt.com)\n\n**BMJ Open**\n\n[Supporting children and young people when making decisions about joining clinical trials: qualitative study to inform multimedia website development ](https:\u002F\u002Fbmjopen.bmj.com\u002Fcontent\u002F9\u002F1\u002Fe023984)",{"url":633,"width":107,"height":107},"treca-content-5-2x.png",{"pageTitle":541,"pageDescription":541},"\u002Fpages\u002Ftreca.en",{"title":541},"pages\u002Ftreca.en","892tkwwx8D4NPyuJLfKL5fVgb5XfBANCOQNcmYiQmEE",[640,722,790,869,942,973],{"id":641,"title":65,"body":78,"description":78,"extension":5,"meta":642,"navigation":18,"path":718,"seo":719,"stem":720,"__hash__":721},"solutionPages\u002Fsolutions\u002Fdissemination.en.json",{"pageTitle":65,"pageMetadata":643,"page_content":646,"pageSocialShare":716},{"htmlTitle":644,"htmlDesc":645},"Dissemination Solution | Share Your Research | Morph","Share your research results with participants and the public using Morph's Dissemination solution - a results animation and dedicated dissemination website.",[647,654,661,676,681,682,683,715],{"type":85,"sectionSettings":648,"settings":649,"title":650,"text":651,"image":652},{"textAlign":87},{"imgPosition":89},"# Dissemination solution","Share research results and outputs using a dedicated website and animation.",{"url":653,"width":94,"height":95},"header-character-ipad-and-data-2x.png",{"type":97,"sectionSettings":655,"settings":656,"text":657,"image":658,"links":660},{"textAlign":87},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103,"includeCTAs":18},"### Our dissemination solution helps you share your study's findings clearly and effectively.\n\nIt combines a short explainer animation with a dedicated website, creating a structured and accessible way to present your results in one place. Together, they offer a consistent and lasting way to share research with participants, the public, healthcare professionals, and funders.\n\n* **Dissemination Animation** - 2D explainer presenting your study findings\n* **Dissemination Website** - public website for study results and outputs\n\nThe animation communicates key outcomes in a concise format, while the website provides a public home for publications, reports, and other study outputs. The solution supports multi-language delivery and is designed to be responsive across desktop, tablet and mobile, fully supported, and available in multiple languages.",{"url":659,"width":323,"height":324},"content-shape-hand-ipad-results-2x.png",[],{"type":303,"sectionSettings":662,"settings":663,"text":664,"accordionItems":665},{"textAlign":87},{"accordionHeaderLevel":129,"accordionHeaderFontSize":156,"accordionTheme":102,"accordionItemsCollapsed":18,"accordionSingleOpenItem":18,"accordionScrollToTopOnOpen":18},"## Solution details",[666,671],{"icon":667,"title":669,"content":670},{"iconSize":161,"iconName":668},"content-dissemination-website","Dissemination Website","### Key features\n\n* The Dissemination Website provides a dedicated online space to share the findings and outputs from your research.\n* It brings together key materials such as your Dissemination Animation, links to publications, infographics, reports, Plain English summaries, and other study outputs.\n* We can match your existing study branding or create a bespoke design and apply it consistently across the site.\n* The site is responsive, accessible, and easy to navigate across desktop, tablet, and mobile.\n* It is designed to be accessible for people with different needs and meets WCAG 2.1 AA standards.\n* The site supports multi-language delivery, allowing written content and animations to be switched between languages.\n* Dissemination websites can support funder requirements around public reporting and provide a permanent online record of your study.",{"icon":672,"title":674,"content":675},{"iconSize":161,"iconName":673},"content-dissemination-animation","Dissemination Animation","### Key features\n\n* We turn your study findings into a clear, engaging 2D explainer animation that provides an overview of the key outcomes and messages from your research.\n* The animations can be used in presentations, shared on study websites, embedded in reports, or distributed across social media to help communicate findings more widely.\n* The animations are typically two or three minutes long and include a voiceover and a simple set of sound effects.\n* We provide an image pack of illustrations from the storyboard and a series of short social clips for use across print, web, and social channels.\n* We can produce versions for different groups — for example, participants, the public, or healthcare professionals — as well as versions in multiple languages.\n* Our process is straightforward and our pricing is all-inclusive.",{"type":221,"sectionSettings":677,"settings":679,"text":680},{"textAlign":126,"sectionLabel":678,"theme":102},"Testimonial",{"btnTheme":102,"stackBtns":103},"> **The animation will be an invaluable tool to help us to share the findings of the research in a clear accessible way and hopefully get the technique more widely used across the NHS.**\n\nProfessor Christine O'Farrelly, University of Cambridge",{"type":363},{"type":360,"isCurrentSolution":65},{"type":124,"sectionSettings":684,"settings":685,"text":686,"cards":687},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},"## Dissemination projects",[688,695,703,710],{"type":134,"imgPosition":89,"strapline":372,"title":689,"summary":225,"image":690,"link":692,"categories":694},"CTT Study",{"url":691,"width":139,"height":376},"morph-work-card-ctt-2x.png",{"url":693},"\u002Fwork\u002Fctt-study",[50],{"type":134,"imgPosition":89,"strapline":696,"title":697,"image":698,"link":700,"categories":702},"UWE Bristol","FRONTIER Study",{"url":699,"width":139,"height":376},"morph-work-card-frontier-2x.png",{"url":701},"\u002Fwork\u002Ffrontier-study",[50,65],{"type":134,"imgPosition":89,"strapline":372,"title":704,"image":705,"link":707,"categories":709},"SCIENCE Trial",{"url":706,"width":139,"height":376},"morph-work-card-image 3@2x.png",{"url":708},"\u002Fwork\u002Fscience-trial",[70,65,60],{"type":134,"imgPosition":89,"strapline":397,"title":711,"image":712,"link":713,"categories":714},"Healthy Start, Happy Start",{"url":400,"width":139,"height":376},{"url":402},[65,50],{"type":405,"text":680},{"pageTitle":717,"pageDescription":717},"Morph solutions - Dissemination","\u002Fsolutions\u002Fdissemination.en",{"title":65},"solutions\u002Fdissemination.en","Vp9Ey6QIwHivwalVMnfhAmQQcEh7PwEm1rSt6JsihLw",{"id":723,"title":50,"body":78,"description":78,"extension":5,"meta":724,"navigation":18,"path":786,"seo":787,"stem":788,"__hash__":789},"solutionPages\u002Fsolutions\u002Fexplainer.en.json",{"pageTitle":50,"pageMetadata":725,"page_content":728,"pageSocialShare":784},{"htmlTitle":726,"htmlDesc":727},"Explainer Solution | 2D Clinical Trial Animation | Morph","Morph's Explainer solution: a 2–3 minute 2D animation that clearly explains your trial or research - supported by an image pack and social media clips.",[729,736,743,755,759,760,761,783],{"type":85,"sectionSettings":730,"settings":731,"title":732,"text":733,"image":734},{"textAlign":87},{"imgPosition":89},"# Explainer animation","Explain your study, patient information or results using 2D animation.",{"url":735,"width":94,"height":95},"header-solutions-explainer-2x.png",{"type":97,"sectionSettings":737,"settings":738,"text":739,"image":740,"links":742},{"textAlign":87},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103,"includeCTAs":18},"### We can create a bespoke 2D explainer animation to communicate your key research messages.\n\nExplainer animations provide a clear and engaging way to help audiences understand complex information, whether that’s supporting recruitment, participation, or sharing results. The design, tone, and content are tailored to your aims and audience, and can be delivered in different languages to reach diverse and hard to reach groups.\n\n* **Patient Information Animation** - 2D explainer summarising your PIS\u002FPIL\n* **Dissemination Animation** - 2D explainer presenting your study findings\n\nThese are our most common animation types, but we can also create animations to explain treatments, processes, or other aspects of healthcare and research.\n\nThis solution includes one animation, but additional animations in the same style can be produced if required. For example, you may wish to commission an animation to explain a specific treatment alongside a Patient Information Animation, or a Dissemination Animation to follow once results are known.",{"url":741,"width":323,"height":324},"content-character-child-ipad-explainer-2x.png",[],{"type":303,"sectionSettings":744,"settings":745,"text":664,"accordionItems":746},{"textAlign":78},{"accordionHeaderLevel":129,"accordionHeaderFontSize":156,"accordionTheme":102,"accordionItemsCollapsed":18,"accordionSingleOpenItem":18,"accordionScrollToTopOnOpen":18},[747,752],{"icon":748,"content":750,"title":751},{"iconSize":161,"iconName":749},"content-patient-information-animation","### Key features\n\n* We turn your Patient Information Sheet into a clear, engaging 2D explainer animation that’s easy for participants to understand.\n* The animations are typically two or three minutes long and include a voiceover and a simple set of sound effects.\n* We provide an image pack of illustrations from the storyboard and a series of short social clips for use across print, web, and social channels.\n* Animation is a valuable way to involve PPI groups, with opportunities for input at the design, script, and storyboard stages.\n* We can produce versions in different languages and tailor content for specific audiences, helping to reach diverse or harder-to-reach groups.\n* Our process is straightforward and our pricing is all-inclusive.","Patient Information Animation",{"icon":753,"title":674,"content":754},{"iconSize":161,"iconName":673},"### Key features\n\n* We turn your study findings into a clear, engaging 2D explainer animation that provides an overview of the key outcomes and messages from your research.\n* The animations are typically two or three minutes long and include a voiceover and a simple set of sound effects.\n* We provide an image pack of illustrations from the storyboard and a series of short social clips for use across print, web, and social channels.\n* We can produce versions for different groups — for example, participants, the public, or healthcare professionals — as well as versions in multiple languages.\n* Our process is straightforward and our pricing is all-inclusive.",{"type":221,"sectionSettings":756,"settings":757,"text":758},{"textAlign":126,"theme":102,"sectionLabel":678},{"btnTheme":102,"stackBtns":103},"> **Our team think the animation is brilliant – it was even better than we hoped. Morph has been a great partner working with the research teams from Imperial College London Trials Unit and the University of Cambridge. The animation will be an invaluable tool to help us to share the findings of the research in a clear accessible way and hopefully get the technique more widely used across the NHS.**\n\nProfessor Christine O’Farrelly, University of Cambridge",{"type":363},{"type":360,"isCurrentSolution":50},{"type":124,"sectionSettings":762,"settings":763,"text":369,"cards":764},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[765,769,774,778],{"type":134,"imgPosition":89,"strapline":372,"title":373,"summary":225,"image":766,"link":767,"categories":768},{"url":375,"width":139,"height":376},{"url":378},[50],{"type":134,"imgPosition":89,"strapline":397,"title":711,"image":770,"link":771,"categories":773},{"url":400,"width":139,"height":376},{"url":772},"\u002Fwork\u002Fcrafft-trial",[60],{"type":134,"imgPosition":89,"strapline":696,"title":697,"image":775,"link":776,"categories":777},{"url":699,"width":139,"height":376},{"url":701},[70,65,60],{"type":134,"imgPosition":89,"strapline":372,"title":689,"image":779,"link":781,"categories":782},{"url":780,"width":139,"height":376},"morph-work-card-image 11@2x.png",{"url":693},[50,65],{"type":405},{"pageTitle":785,"pageDescription":785},"Morph solutions - Explainer","\u002Fsolutions\u002Fexplainer.en",{"title":50},"solutions\u002Fexplainer.en","hd4LehrLUpgsHYDaAb2UTa6yq8aRdxkmt6UTLE78L8Q",{"id":791,"title":70,"body":78,"description":78,"extension":5,"meta":792,"navigation":18,"path":865,"seo":866,"stem":867,"__hash__":868},"solutionPages\u002Fsolutions\u002Flifecycle.en.json",{"pageTitle":70,"pageMetadata":793,"page_content":796,"pageSocialShare":863},{"htmlTitle":794,"htmlDesc":795},"Lifecycle Solution | Full Clinical Trial Support | Morph","Morph's Lifecycle solution supports your trial from recruitment to results - combining all five communication products in one comprehensive package.",[797,804,811,832,836,838,839,862],{"type":85,"sectionSettings":798,"settings":799,"title":800,"text":801,"image":802},{"textAlign":87},{"imgPosition":89},"# Lifecycle solution","Complete solution to support your study from recruitment through to results.",{"url":803,"width":94,"height":95},"header-devices-and-screens-2x.png",{"type":97,"sectionSettings":805,"settings":806,"text":807,"image":808,"links":810},{"textAlign":87},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103,"includeCTAs":18},"### This solution brings together patient information, study communications, and dissemination materials.\n\nTogether, they provide a coordinated set of materials across the full lifecycle of a study. The Patient Information Tool supports understanding during recruitment. The Study Website provides a clear public home for the trial. Dissemination materials support the sharing of study results and outputs.\n\n* **Patient Information Animation** - 2D explainer summarising your PIS\u002FPIL\n* **Patient Information Tool** - step-by-step web tool presenting your PIS\u002FPIL\n* **Study Website** - public website for study information and resources\n* **Dissemination Animation** - 2D explainer presenting your study findings\n* **Dissemination Website** - public website for study results and outputs\n\nWe populate the Patient Information Tool with text from the approved PIS\u002FPIL and the Study Website with trial-specific content as a starting point. The web elements are designed to be accessible, responsive across desktop, tablet, and mobile, fully supported, and available in multiple languages.",{"url":809,"width":323,"height":324},"content-solutions-toolkit-2x.png",[],{"type":303,"sectionSettings":812,"settings":813,"text":814,"accordionItems":815},{"textAlign":87},{"accordionHeaderLevel":129,"accordionHeaderFontSize":156,"accordionTheme":102,"accordionItemsCollapsed":18,"accordionSingleOpenItem":18,"accordionScrollToTopOnOpen":18},"## Lifecycle details",[816,818,823,828,830],{"icon":817,"title":751,"content":750},{"iconSize":161,"iconName":749},{"icon":819,"title":821,"content":822},{"iconSize":161,"iconName":820},"content-patient-information-tool","Patient Information Tool","### Key features\n\n* We convert your Patient Information Sheet (PIS\u002FPIL) into an interactive web tool.\n* It presents study information in a clear, step-by-step format, supporting participant understanding and informed decision-making.\n* The tool is displayed in full screen mode to reduce distractions and starts with the Patient Information Animation. It features simple, accessible design with clear navigation and responsive layouts across desktop, tablet, and mobile.\n* We populate the tool with the text from your approved Patient Information Sheet and style it to match the trial branding.\n* The Patient Information Tool, including the animation, can be switched between languages, with language selection controlled by the user.\n* It is designed to be accessible for people with different needs and meets WCAG 2.1 AA standards.\n* Secure hosting is included, and we provide ongoing support and content updates if study materials change.\n* The tool can be used face to face on a tablet, accessed through a study website, or shared remotely by email, text, or social media.",{"icon":824,"title":826,"content":827},{"iconSize":161,"iconName":825},"content-study-website","Study Website","### Key features\n\n* The Study Website provides a professional public face for your clinical trial.\n* It features simple, accessible design, clear navigation, and responsive layouts across desktop, tablet, and mobile.\n* The site can act as a hub for the research, bringing together information about the study, research team, locations, eligibility, and ways of getting in touch.\n* We populate the site with trial-specific content from the protocol or funding award as a starting point, and the layout can be adapted to suit the study design.\n* We can create or refine your study logo and branding and apply it consistently across all elements.\n* It is designed to be accessible for people with different needs and meets WCAG 2.1 AA standards.\n* The site supports multi-language delivery, allowing written content and animations to be switched between languages.\n* Secure hosting is included, and we provide ongoing support and content updates as the study progresses.",{"icon":829,"title":669,"content":670},{"iconSize":161,"iconName":668},{"icon":831,"title":674,"content":675},{"iconSize":161,"iconName":673},{"type":221,"sectionSettings":833,"settings":834,"text":835},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> Working with the Morph team is great - I’ve worked with them over several studies, and they understand clinical research and what a study needs to be successful. They really become part of the team!\n\nProfessor Dan Perry, University of Liverpool",{"type":363,"text":837},"> **Working with the Morph team is great - I’ve worked with them over several studies, and they understand clinical research and what a study needs to be successful. They really become part of the team!**\n\nProfessor Dan Perry, University of Liverpool",{"type":360,"isCurrentSolution":70},{"type":124,"sectionSettings":840,"settings":841,"text":369,"cards":842},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[843,848,854,858],{"type":134,"imgPosition":89,"strapline":372,"title":704,"image":844,"link":846,"categories":847},{"url":845,"width":139,"height":376},"morph-work-card-science-2x.png",{"url":708},[70,65,60],{"type":134,"imgPosition":89,"strapline":372,"title":849,"image":850,"link":852,"categories":853},"CRAFFT Trial",{"url":851,"width":139,"height":376},"morph-work-card-crafft-2x.png",{"url":772},[60],{"type":134,"imgPosition":89,"strapline":389,"title":390,"image":855,"link":856,"categories":857},{"url":392,"width":139,"height":376},{"url":394},[55,50,60],{"type":134,"imgPosition":89,"strapline":381,"title":382,"image":859,"link":860,"categories":861,"summary":225},{"url":384,"width":139,"height":376},{"url":386},[50,60,55],{"type":405},{"pageTitle":864,"pageDescription":864},"Morph solutions - Lifecycle","\u002Fsolutions\u002Flifecycle.en",{"title":70},"solutions\u002Flifecycle.en","aiOi1IVHVr0lzr2kW56n2nwZYvTl1U2Sq5Tzu8axwE4",{"id":870,"title":55,"body":78,"description":78,"extension":5,"meta":871,"navigation":18,"path":938,"seo":939,"stem":940,"__hash__":941},"solutionPages\u002Fsolutions\u002Fpatient-info.en.json",{"pageTitle":55,"pageMetadata":872,"page_content":875,"pageSocialShare":936},{"htmlTitle":873,"htmlDesc":874},"Patient Info Solution | Animation & Digital PIS | Morph","Morph's Patient Info solution pairs a Patient Information Animation with a digital Patient Information Tool - helping participants understand your trial.",[876,883,889,897,902,903,904,935],{"type":85,"sectionSettings":877,"settings":878,"title":879,"text":880,"image":881},{"textAlign":87},{"imgPosition":89},"# Patient Information Tool","Convert your PIS\u002FPIL into a patient information tool with supporting 2D animation.",{"url":882,"width":94,"height":95},"header-solutions-patient-info-2x.png",{"type":97,"sectionSettings":884,"settings":885,"text":886,"image":887},{"textAlign":87},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103,"includeCTAs":18},"### The Patient Info Tool (PIT) is a flexible, engaging way to deliver patient information online.\n\nThe PIT displays in full screen mode to reduce distractions, it starts with the Patient Information Animation which provides a simplified overview of the PIS, before presenting the written information from the PIS\u002FPIL in short, easy-to-read sections delivered step by step.\n\n* **Patient Information Animation** - 2D explainer summarising your PIS\u002FPIL\n* **Patient Information Tool** - step-by-step web tool presenting your PIS\u002FPIL\n\nThe tool addresses the challenge of delivering patient information in a clearer, more accessible way. It presents the most important information up front, while ensuring the full approved content remains available. The tool is fully accessible, responsive across devices, and available in multiple languages.\n\nIt can be used face to face on a tablet, for example in emergency settings, linked to from a study site, or accessed via text message, email, or QR code.",{"url":888,"width":323,"height":324},"content-shape-character-wheelchair-laptop-2x.png",{"type":303,"sectionSettings":890,"settings":891,"text":664,"accordionItems":892},{"textAlign":87},{"accordionHeaderLevel":129,"accordionHeaderFontSize":156,"accordionTheme":102,"accordionItemsCollapsed":18,"accordionSingleOpenItem":18,"accordionScrollToTopOnOpen":18},[893,895],{"icon":894,"title":821,"content":822},{"iconSize":161,"iconName":820},{"icon":896,"title":751,"content":750},{"iconSize":161,"iconName":749},{"type":221,"sectionSettings":898,"settings":900,"text":901},{"textAlign":126,"sectionLabel":899,"theme":102},"Ryan Ottridge Testimonial",{"btnTheme":102,"stackBtns":103},"> **Our research assistants love the transformation of the patient information sheet into the participant information tool. Being able to send the patient information by text or qr code is an excellent extra way to generate interest in the trial. Many have reported back unprompted that it helps them with recruiting our difficult patient population and I’ve now started planning in a Morph patient information tool for all of my projects.**\n\nRyan Ottridge, Senior Trial Manager, University of Birmingham",{"type":363},{"type":360,"isCurrentSolution":55},{"type":124,"sectionSettings":905,"settings":906,"text":369,"cards":907},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[908,916,924,928],{"type":134,"imgPosition":89,"strapline":909,"title":910,"summary":225,"image":911,"link":913,"categories":915},"University of Warwick","Big TOE",{"url":912,"width":139,"height":376},"morph-work-card-big-toe-2x.png",{"url":914},"\u002Fwork\u002Fbig-toe-trial",[50],{"type":134,"imgPosition":89,"strapline":917,"title":918,"image":919,"link":921,"categories":923},"QMUL","TILLI Study",{"url":920,"width":139,"height":376},"morph-work-card-tilli-2x.png",{"url":922},"\u002Fwork\u002Ftilli-study",[50,65],{"type":134,"imgPosition":89,"strapline":372,"title":849,"image":925,"link":926,"categories":927},{"url":851,"width":139,"height":376},{"url":772},[60],{"type":134,"imgPosition":89,"strapline":372,"title":929,"image":930,"link":932,"categories":934},"ACL STARR Study",{"url":931,"width":139,"height":376},"morph-work-card-acl-starr-2x.png",{"url":933},"\u002Fwork\u002Facl-starr-study",[70,65,60],{"type":405},{"pageTitle":937,"pageDescription":937},"Morph solutions - Patient Info","\u002Fsolutions\u002Fpatient-info.en",{"title":55},"solutions\u002Fpatient-info.en","8Fhm_6xXWAVjfytBtZwXcXeyB5lxYE4f2FBU2yT8CaY",{"id":943,"title":21,"body":78,"description":78,"extension":5,"meta":944,"navigation":18,"path":969,"seo":970,"stem":971,"__hash__":972},"solutionPages\u002Fsolutions\u002Findex.en.json",{"pageTitle":21,"pageMetadata":945,"page_content":948,"pageSocialShare":968},{"htmlTitle":946,"htmlDesc":947},"Clinical Trial Communication Solutions | Morph","Explore Morph's five communication solutions for clinical trials - from patient information animations and tools to study websites and dissemination packages.",[949,956,960,965,967],{"type":85,"sectionSettings":950,"settings":951,"title":952,"text":953,"image":954},{"textAlign":87},{"imgPosition":89},"# Solutions","Find the right solution for your study, or get in touch to discuss a bespoke approach.",{"url":955,"width":94,"height":95},"morph-header-image 4@2x.png",{"type":355,"sectionSettings":957,"textCol1":958,"textCol2":959},{"textAlign":87},"The table below shows our five core solutions, with key products, features, and optional add-ons.","Solutions range from individual explainer animations to complete study communication packages. \n\nAll products are accessible by design and are available in multiple languages to support a wide range of participants.\n\nWhere a different approach is needed, we can adapt what we deliver to suit your study.",{"type":248,"sectionSettings":961,"componentName":963,"text":964},{"textAlign":126,"customClass":962},"full-width","MorphSolutionsTable","## Compare solutions and features",{"type":360,"text":966},"## Morph solutions",{"type":405},{"pageTitle":21,"pageDescription":21},"\u002Fsolutions\u002Findex.en",{"title":21},"solutions\u002Findex.en","oI3wJXHttMqRwtENzbBjyIWV7CIOLeokDgnnjI297dw",{"id":974,"title":60,"body":78,"description":78,"extension":5,"meta":975,"navigation":18,"path":1039,"seo":1040,"stem":1041,"__hash__":1042},"solutionPages\u002Fsolutions\u002Fstudy.en.json",{"pageTitle":60,"pageMetadata":976,"page_content":979,"pageSocialShare":1037},{"htmlTitle":977,"htmlDesc":978},"Study Solution | Complete Clinical Trial Presence | Morph","Morph's Study solution provides a complete public presence for your trial: Patient Information Animation, Patient Information Tool, and a Study Website.",[980,987,994,1004,1009,1010,1011,1036],{"type":85,"sectionSettings":981,"settings":982,"title":983,"text":984,"image":985},{"textAlign":87},{"imgPosition":89},"# Study solution","Public-facing study website to support recruitment and patient understanding.",{"url":986,"width":94,"height":95},"header-character-doctor-screen-2x.png",{"type":97,"sectionSettings":988,"settings":989,"text":990,"image":991,"links":993},{"textAlign":87},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103,"includeCTAs":18},"### This solution brings together key study information and participant resources in one clear, consistent online space.\n\nThe study website acts as a public home for the trial, bringing together details such as the research team, locations, eligibility, all tailored to the individual study. The Patient Information Tool, including the animation, presents the PIS\u002FPIL in a clear, step-by-step format, supporting participant understanding and informed decision-making.\n\n* **Patient Information Animation** - 2D explainer summarising your PIS\u002FPIL\n* **Patient Information Tool** - step-by-step web tool presenting your PIS\u002FPIL\n* **Study Website** - public website for study information and resources\n\nWe populate the Patient Information Tool with text from the approved PIS\u002FPIL and the Study Website with trial-specific content as a starting point. The solution is accessible, responsive across desktop, tablet, and mobile, fully supported, and available in multiple languages, making it suitable for both traditional and decentralised trial designs.",{"url":992,"width":323,"height":324},"content-shape-hand-laptop-studysite-2x.png",[],{"type":303,"sectionSettings":995,"settings":996,"accordionItems":997,"text":664},{"textAlign":87},{"accordionHeaderLevel":129,"accordionHeaderFontSize":156,"accordionTheme":102,"accordionItemsCollapsed":18,"accordionSingleOpenItem":18,"accordionScrollToTopOnOpen":18},[998,1000,1002],{"icon":999,"content":750,"title":751},{"iconSize":161,"iconName":749},{"icon":1001,"content":822,"title":821},{"iconSize":161,"iconName":820},{"icon":1003,"content":827,"title":826},{"iconSize":161,"iconName":825},{"type":221,"sectionSettings":1005,"settings":1007,"text":1008},{"textAlign":126,"sectionLabel":1006,"theme":102},"Rob Jones Testimonial",{"btnTheme":102,"stackBtns":103},"> **It was really easy to share the site via QR codes, email and WhatsApp which meant doctors and patients could link into the study really really easily. The UK recruited to the trial 4 times as fast as anywhere else in the world and a huge part of that was down to the Morph site.**\n\nProfessor Rob Jones, Consultant Hepatobiliary Surgeon, University of Liverpool",{"type":363},{"type":360,"isCurrentSolution":60},{"type":124,"sectionSettings":1012,"settings":1013,"text":369,"cards":1014},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[1015,1019,1027,1032],{"type":134,"imgPosition":89,"strapline":381,"title":382,"summary":225,"image":1016,"link":1017,"categories":1018},{"url":384,"width":139,"height":376},{"url":386},[50],{"type":134,"imgPosition":89,"strapline":1020,"title":1021,"image":1022,"link":1024,"categories":1026},"BIONTECH","BNT122",{"url":1023,"width":139,"height":376},"morph-work-card-bnt122-2x.png",{"url":1025},"\u002Fwork\u002Fbnt122-study",[50,65],{"type":134,"imgPosition":89,"strapline":1028,"title":390,"image":1029,"link":1030,"categories":1031},"University of Liverpool ",{"url":392,"width":139,"height":376},{"url":394},[60],{"type":134,"imgPosition":89,"strapline":372,"title":704,"image":1033,"link":1034,"categories":1035},{"url":845,"width":139,"height":376},{"url":708},[70,65,60],{"type":405},{"pageTitle":1038,"pageDescription":1038},"Morph solutions - Study","\u002Fsolutions\u002Fstudy.en",{"title":60},"solutions\u002Fstudy.en","BlVM856Fw_YyywmIe9xXOIToiW9G0U0nGjzlNPySZQI",[1044,1140,1227,1314,1403,1484,1576,1657,1738,1827,1913,1998,2063,2148,2229,2311,2402,2490],{"id":1045,"title":929,"body":78,"description":78,"extension":5,"meta":1046,"navigation":18,"path":1136,"seo":1137,"stem":1138,"__hash__":1139},"workPages\u002Fwork\u002Facl-starr-study.en.json",{"pageTitle":929,"pageMetadata":1047,"page_content":1050,"pageSocialShare":1135},{"htmlTitle":1048,"htmlDesc":1049},"ACL STARR Study | Knee Ligament Surgery Trial | Morph","Patient animation, Patient Information Tool, and study website for the ACL STARR trial at the University of Oxford - later adapted for an Australian site.",[1051,1058,1071,1075,1082,1086,1094,1112,1134],{"type":85,"sectionSettings":1052,"settings":1053,"title":1054,"text":1055,"strapline":372,"image":1056},{"textAlign":87},{"imgPosition":89},"# ACL STARR Study","Anterior Cruciate Ligament Stratified Accelerated Repair.",{"url":1057,"width":94,"height":95},"acl-starr-work-header-2x.png",{"type":1059,"sectionSettings":1060,"maxLogosPerRow":129,"logos":1062},"text_and_logos",{"textAlign":87,"sectionLabel":1061},"Project logos",[1063,1065,1068],{"url":1064,"alt":381},"morph-client-logo-birmingham-lighter-bg@2x.png",{"url":1066,"alt":1067},"morph-client-logo-lancaster-lighter-bg@2x.png","Lancaster University",{"url":1069,"alt":1070},"morph-client-logo-leeds-lighter-bg@2x.png","University of Leeds",{"type":355,"sectionSettings":1072,"textCol1":1073,"textCol2":1074},{"textAlign":87},"The ACL STARR Study compares two surgical approaches for treating a torn anterior cruciate ligament (ACL).","The ACL is a key ligament that stabilises the knee and is commonly injured during sport or physical activity. ACL injuries can lead to long-term knee instability and increase the risk of developing osteoarthritis later in life.\n\nThe study is investigating whether repairing the existing ligament provides better outcomes than ACL reconstruction, the standard procedure where the ligament is replaced with tissue taken from elsewhere in the body.",{"type":97,"sectionSettings":1076,"settings":1078,"title":225,"text":1079,"image":1080},{"textAlign":87,"sectionLabel":1077},"Morph Solution",{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"### Morph solution\n\n**Morph supported the ACL STARR Study by developing digital tools to help explain the trial and support communication with potential participants.**\n\n* **Patient Information Animation** – a 2D explainer outlining what participation in the study involved, helping people quickly understand the purpose and process.\n* **Participant Information Tool (PIT)** – an interactive digital version of the patient information sheet, guiding participants step by step through key details to support understanding and informed consent.\n* **Study Website** – a professional public-facing hub bringing all trial information together in one accessible place. The animation appears on the homepage and at the start of the Participant Information Tool, providing a clear and consistent introduction for participants.",{"url":1081,"width":323,"height":324},"acl-starr-work-content-2x.png",{"type":221,"sectionSettings":1083,"settings":1084,"text":1085},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> Our collaboration with Morph over the production of the ACL animation was a terrific journey in so many ways. The team were approachable, listened to and acted on the brief - and then used their experience to generate a meaningful and engaging patient aid. We ended up with a first class animation of high relevance to the target audience of ACL injured patients. They even generously adjusted the \"already built\" animation to suit an Australian audience for the mirror trial down under.  Thank you Morph\n\nProfessor David Beard, University of Sydney",{"type":584,"sectionSettings":1087,"settings":1089,"video":1090,"text":225},{"textAlign":87,"sectionLabel":1088},"Work video",{"videoAlign":126},{"vimeoId":1091,"videoTitle":1092,"videoTranscript":1093},"1080540219?h=a3bef81959","The ACL STARR Study video","The ACL STARR study is investigating which is the best surgical option for people who have torn their anterior cruciate ligament, or ACL.\n\nThe ACL is an important band of tissue that supports the knee. It is a strong structure in the centre of the knee. It attaches the thigh bone to the shin bone.\n\nACL injuries can be treated with surgery or rehabilitation physiotherapy. You will decide with your surgeon and family or carers which is more suitable for you.\n\nIf you choose surgery, you may be eligible for this study.\n\nThe ACL STARR study will compare two types of surgery to see which is better. A reconstruction, where the torn ligament is replaced using tissue from elsewhere in your body, or a repair, which means that your torn ligament is kept and repaired. Both are already performed in the NHS.\n\nIf you decide to join the study, we will ask you to sign a consent form and to complete a set of questions about your knee injury.\n\nAt the start of your operation, your surgeon will look at your ligament to make sure it is suitable for either surgery. If repair surgery isn't suitable, you will have reconstruction surgery. You will not be part of the study and will be looked after as normal.\n\nIf it is suitable, your type of surgery will be decided randomly by a computer. Half of our participants will have reconstruction surgery and half will have repair surgery.\n\nWe won't tell you which surgery you've had until after the study has finished.\n\nAfter surgery, you will have physiotherapy to help your recovery.\n\nAt three and six weeks after surgery, we will ask you to complete a pain score. This is a number on a scale from zero to ten, sent by text, email, or post, depending on your choice.\n\nAt six, twelve and twenty-four months after your operation, we will send you a set of questions by email or by post. We want to find out how well you function, walk, run, or play sport two years after surgery.\n\nIt will only take ten minutes to complete each set of questions.\n\nTaking part is voluntary and you can leave at any time.\n\nBy taking part, you'll help us find out which surgery is best for treating torn ACLs.\n\nThe doctors, surgeons and research team are happy to answer any questions about joining the study.",{"type":180,"sectionSettings":1095,"slides":1096},{"textAlign":87},[1097,1102,1107],{"narrowScreenImage":1098,"wideScreenImage":1100},{"url":1099,"width":186,"height":95},"acl-starr-work-slider-mobile-1-2x.jpg",{"url":1101,"width":189,"height":95},"acl-starr-work-slider-desktop-1-2x.jpg",{"narrowScreenImage":1103,"wideScreenImage":1105},{"url":1104,"width":186,"height":95},"acl-starr-work-slider-mobile-2-2x.png",{"url":1106,"width":189,"height":95},"acl-starr-work-slider-desktop-2-2x.png",{"narrowScreenImage":1108,"wideScreenImage":1110},{"url":1109,"width":186,"height":95},"acl-starr-work-slider-mobile-3-2x.jpg",{"url":1111,"width":189,"height":95},"acl-starr-work-slider-desktop-3-2x.jpg",{"type":124,"sectionSettings":1113,"settings":1114,"text":1115,"cards":1116},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},"## Similar Work",[1117,1121,1125,1129],{"type":134,"imgPosition":89,"strapline":381,"title":382,"image":1118,"link":1119,"categories":1120,"summary":225},{"url":384,"width":139,"height":376},{"url":386},[50,60,55],{"type":134,"imgPosition":89,"strapline":372,"title":689,"image":1122,"link":1123,"categories":1124},{"url":691,"width":139,"height":376},{"url":693},[50,65],{"type":134,"imgPosition":89,"strapline":372,"title":704,"image":1126,"link":1127,"categories":1128},{"url":845,"width":139,"height":376},{"url":708},[70,65,60],{"type":134,"imgPosition":89,"strapline":1130,"title":1021,"image":1131,"link":1132,"categories":1133},"BIONTECH ",{"url":1023},{"url":1025},[50,60,55],{"type":405},{"pageTitle":929,"pageDescription":929},"\u002Fwork\u002Facl-starr-study.en",{"title":929},"work\u002Facl-starr-study.en","Qq1e_OzloCb_eQ15GuwSonL5xwkEdFOhe90mQB5T7sI",{"id":1141,"title":1142,"body":78,"description":78,"extension":5,"meta":1143,"navigation":18,"path":1223,"seo":1224,"stem":1225,"__hash__":1226},"workPages\u002Fwork\u002Fadepp-study.en.json","ADEPP Study",{"pageTitle":1142,"pageMetadata":1144,"page_content":1147,"pageSocialShare":1222},{"htmlTitle":1145,"htmlDesc":1146},"ADEPP Study | Psychosis & Mental Health Research | Morph","Morph created sensitive patient communication materials for the ADEPP psychosis study at the University of Birmingham, including an animation and digital PIS.",[1148,1155,1161,1165,1171,1175,1182,1201,1221],{"type":85,"sectionSettings":1149,"settings":1150,"title":1151,"text":1152,"strapline":381,"image":1153},{"textAlign":87},{"imgPosition":89},"# ADEPP Study","Antidepressant for the Prevention of Depression Following First Episode Psychosis.",{"url":1154,"width":94,"height":95},"adepp-work-header-2x.png",{"type":1059,"sectionSettings":1156,"maxLogosPerRow":129,"logos":1157},{"textAlign":87,"sectionLabel":1061},[1158,1159,1160],{"url":1064,"alt":381},{"url":1066,"alt":1067},{"url":1069,"alt":1070},{"type":355,"sectionSettings":1162,"textCol1":1163,"textCol2":1164},{"textAlign":87},"The ADEPP Study investigated treatment following First Episode Psychosis — the first time someone experiences psychotic symptoms.","The Study is investigated whether sertraline can help prevent depression in people experiencing their first episode of psychosis, for example, hallucinations and delusions. Led by the University of Birmingham, the study is testing whether early treatment with sertraline could reduce the risk of depression and support better recovery. The trial is being carried out across multiple NHS sites to build a clearer picture of how best to support people at this early stage of illness.",{"type":97,"sectionSettings":1166,"settings":1167,"title":225,"text":1168,"image":1169},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"## Morph solution\n\n**Morph supported the ADEPP study by creating digital tools to engage participants and streamline informed consent.**\n\n* **Patient Information Animation** – a 2D explainer outlining what participation in ADEPP involved. Designed to communicate sensitive mental health information clearly and respectfully, it helped participants understand the study and its purpose.\n* **Participant Information Tool (PIT)** – an interactive digital version of the patient information sheet, guiding participants step by step through key details to support informed consent in both face-to-face and remote settings.\n* **Study Website** – a professional public-facing hub bringing all trial information together in one accessible place. The site linked directly to the animation and PIT, helping the ADEPP team communicate consistently with potential participants.",{"url":1170,"width":323,"height":324},"adepp-work-content-2x.png",{"type":221,"sectionSettings":1172,"settings":1173,"text":1174},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> The animation is great and really helps to engage, and being able to send the patient information by text or QR code is an excellent extra way to generate interest in the trial. Many have reported back unprompted that it helps them with recruiting our difficult patient population and I’ve now started planning in a Morph patient information tool for all of my projects.\n\nSenior Trial Manager, Ryan Ottridge, University of Birmingham",{"type":584,"sectionSettings":1176,"settings":1177,"video":1178,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":1179,"videoTitle":1180,"videoTranscript":1181},"738959203?h=517cbed530","ADEPP Study video","The ADEPP study is trying to find out if an antidepressant called sertraline can help prevent depression in people who have experienced a psychotic episode for the first time.\n\nA psychotic episode can be a traumatic and frightening experience.\n\n40% of patients will also experience depression and anxiety after a first episode of psychosis.\n\nTypical standard care helps to treat psychotic symptoms but young people often struggle to return to their previous work and social lives. We think this may be related to depression.\n\nSertraline is already used in the NHS for the treatment and prevention of depression in other conditions.\n\nThis study will recruit patients from across England and Wales.\n\nHalf will receive the antidepressant Sertraline Half will receive a placebo, which contains no medicine.\n\nThis enables us to compare the effect of the active treatment sertraline with any effect that may be because someone thinks they have had the active treatment or of any additional monitoring.\n\nThis is done in most good medication trials. No one will choose which treatment they receive. It will be decided randomly.\n\nWe are inviting you to take part because you have experienced First Episode Psychosis.\n\nIf you are interested, we will ask you some questions to see if you are eligible for the study.\n\nIf you are, we will ask you to consent to take part.\n\nThe research team will ask you some more questions about your health and medical history, and you will be allocated your medication to take every day for 6 months.\n\nYou may or may not benefit directly from this medication but you’ll be helping us improve the care for people with psychosis in the future.\n\nAs with any drug, there are possible minor side effects which will be monitored closely, but serious complications are very rare.\n\nWe will also monitor your mood and recovery, which may be helpful for you and your care team to be aware of.\n\nTo assess your progress we will arrange a series of meetings somewhere convenient for you.\n\nThese will be monthly for the first 6 months. Then a final meeting at 12 months.\n\nAt the 1 month visit, we would like to take a blood sample from you to check the level of sertraline in your blood.\n\nAt the 6 month visit we will let you know which medicine you were taking.\n\nYour care team will then decide with you whether to start treatment with Sertraline if you were in the placebo group, or continue or stop if you were in the Sertraline group.\n\nTaking part in this study is voluntary and you can leave at any time.\n\nIf you decide not to take part, your normal care will continue.\n\nAll data will be anonymised and managed legally and securely.\n\nIf you have any questions please contact a member of the research team.",{"type":180,"sectionSettings":1183,"slides":1184},{"textAlign":87},[1185,1191,1196],{"narrowScreenImage":1186,"wideScreenImage":1188},{"url":1187,"width":186,"height":95},"adepp-work-slider-mobile-1-2x.jpg",{"url":1189,"width":189,"height":1190},"adepp-work-slider-desktop-1-2x.jpg",1080,{"narrowScreenImage":1192,"wideScreenImage":1194},{"url":1193,"width":186,"height":95},"adepp-work-slider-mobile-2-2x.png",{"url":1195,"width":189,"height":1190},"adepp-work-slider-desktop-2-2x.png",{"narrowScreenImage":1197,"wideScreenImage":1199},{"url":1198,"width":186,"height":95},"adepp-work-slider-mobile-3-2x.jpg",{"url":1200,"width":189,"height":1190},"adepp-work-slider-desktop-3-2x.jpg",{"type":124,"sectionSettings":1202,"settings":1203,"text":1115,"cards":1204},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[1205,1209,1213,1217],{"type":134,"imgPosition":89,"strapline":381,"title":382,"image":1206,"link":1207,"categories":1208,"summary":225},{"url":384,"width":139,"height":376},{"url":386},[50,60,55],{"type":134,"imgPosition":89,"strapline":372,"title":689,"image":1210,"link":1211,"categories":1212},{"url":691,"width":139,"height":376},{"url":693},[50,65],{"type":134,"imgPosition":89,"strapline":372,"title":704,"image":1214,"link":1215,"categories":1216},{"url":845,"width":139,"height":376},{"url":708},[70,65,60],{"type":134,"imgPosition":89,"strapline":1130,"title":1021,"image":1218,"link":1219,"categories":1220},{"url":1023},{"url":1025},[50,60,55],{"type":405},{"pageTitle":1142,"pageDescription":1142},"\u002Fwork\u002Fadepp-study.en",{"title":1142},"work\u002Fadepp-study.en","AxF8sQ24zpp2tQDjFw1Bjp1-_lNUQOrixvROXnhNvi8",{"id":1228,"title":1229,"body":78,"description":78,"extension":5,"meta":1230,"navigation":18,"path":1310,"seo":1311,"stem":1312,"__hash__":1313},"workPages\u002Fwork\u002Fbnt122-study.en.json","BNT122 Study",{"pageTitle":1229,"pageMetadata":1231,"page_content":1234,"pageSocialShare":1309},{"htmlTitle":1232,"htmlDesc":1233},"BNT122 Study | Personalised Cancer Vaccine Trial | Morph","Patient Information Animation, Tool, and study website for BioNTech's BNT122 personalised cancer vaccine trial - available in five European languages.",[1235,1243,1249,1253,1259,1263,1270,1288,1308],{"type":85,"sectionSettings":1236,"settings":1237,"title":1238,"text":1239,"strapline":1240,"image":1241},{"textAlign":87},{"imgPosition":89},"# BNT122 Study","Same day and urgent care workforce research partnership (SURGE).","Biontech",{"url":1242,"width":94,"height":95},"bnt122-work-header-2x.png",{"type":1059,"sectionSettings":1244,"maxLogosPerRow":129,"logos":1245},{"textAlign":87,"sectionLabel":1061},[1246,1247,1248],{"url":1064,"alt":381},{"url":1066,"alt":1067},{"url":1069,"alt":1070},{"type":355,"sectionSettings":1250,"textCol1":1251,"textCol2":1252},{"textAlign":87},"The BNT122-01 Study is investigating a personalised cancer vaccine for people with colorectal cancer.","The BNT122-01 Study is a Phase II clinical trial evaluating a new personalised cancer vaccine designed to help the immune system recognise and attack cancer cells. The vaccine is created using genetic information from an individual patient’s tumour, allowing it to target features specific to that cancer. The study is investigating whether this approach can reduce the risk of cancer returning in people with high-risk colorectal cancer following surgery and chemotherapy.",{"type":97,"sectionSettings":1254,"settings":1255,"title":225,"text":1256,"image":1257},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"### Morph solution\n\n**Morph supported the BNT122-01 study with our Study Solution, delivering a Patient Information Animation, Patient Information Tool and Study Website to help explain this complex international trial to potential participants.**\n\n* **Patient Information Animation** — a clear 2D explainer summarising how the personalised vaccine works and what taking part in the study involves, helping participants understand the trial before reviewing the full written information.\n* **Patient Information Tool (PIT)** — an interactive digital version of the Patient Information Sheet presenting the study information in structured, step-by-step sections to support participant understanding and informed decision-making.\n* **Study Website** — a dedicated study site bringing together the animation and information tool in one accessible place, providing a clear public home for the study and helping research teams communicate consistently with potential participants.\n\nAll deliverables were produced in five European languages, with language selection controlled by the user.",{"url":1258,"width":323,"height":324},"bnt122-work-content-2x.png",{"type":221,"sectionSettings":1260,"settings":1261,"text":1262},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> The trial website was an absolute game changer for us. A patient friendly, easy to navigate animated patient information site meant patients could get their heads round a complex trial in 90 seconds. Patients and families loved it, and almost always used it in preference to the paper Patient Information Sheets. \n\nProfessor Rob Jones, Consultant Hepatobiliary Surgeon, University of Liverpool",{"type":584,"sectionSettings":1264,"settings":1265,"video":1266,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":1267,"videoTitle":1268,"videoTranscript":1269},"883970716?h=f51edeb720","BNT122 Study Animation","Your body’s immune system is designed to recognise and destroy abnormal cells.\n\nCancer cells can sometimes avoid being detected by the immune system.\n\nThis means the body may not recognise the cancer cells as something that needs to be attacked.\n\nResearchers are investigating new ways to help the immune system recognise and fight cancer more effectively.\n\nOne approach is a personalised cancer vaccine.\n\nThis type of vaccine is created using information from an individual patient’s tumour.\n\nScientists analyse the tumour and identify specific markers that are unique to that cancer.\n\nThese markers are then used to design a vaccine tailored to that individual patient.\n\nThe aim is to train the immune system to recognise and attack cells that carry these markers.\n\nThe BNT122-01 study is investigating this personalised vaccine approach.\n\nThe study is looking at whether the vaccine can help reduce the risk of cancer returning after treatment.\n\nIf you decide to take part in the study, your doctor will explain what participation involves.\n\nTaking part is voluntary and you can leave the study at any time.\n\nThe results of this research may help develop new ways of treating cancer in the future.",{"type":180,"sectionSettings":1271,"slides":1272},{"textAlign":87},[1273,1278,1283],{"narrowScreenImage":1274,"wideScreenImage":1276},{"url":1275,"width":186,"height":95},"bnt122-work-slider-mobile-1-2x.jpg",{"url":1277,"width":189,"height":1190},"bnt122-work-slider-desktop-1-2x.jpg",{"narrowScreenImage":1279,"wideScreenImage":1281},{"url":1280,"width":186,"height":95},"bnt122-work-slider-mobile-2-2x.png",{"url":1282,"width":189,"height":95},"bnt122-work-slider-desktop-2-2x.png",{"narrowScreenImage":1284,"wideScreenImage":1286},{"url":1285,"width":186,"height":95},"bnt122-work-slider-mobile-3-2x.png",{"url":1287,"width":189,"height":1190},"bnt122-work-slider-desktop-3-2x.png",{"type":124,"sectionSettings":1289,"settings":1290,"text":1115,"cards":1291},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[1292,1296,1300,1304],{"type":134,"imgPosition":89,"strapline":381,"title":382,"image":1293,"link":1294,"categories":1295,"summary":225},{"url":384,"width":139,"height":376},{"url":386},[50,60,55],{"type":134,"imgPosition":89,"strapline":372,"title":689,"image":1297,"link":1298,"categories":1299},{"url":691,"width":139,"height":376},{"url":693},[50,65],{"type":134,"imgPosition":89,"strapline":372,"title":704,"image":1301,"link":1302,"categories":1303},{"url":845,"width":139,"height":376},{"url":708},[70,65,60],{"type":134,"imgPosition":89,"strapline":372,"title":929,"image":1305,"link":1306,"categories":1307},{"url":931,"width":139,"height":376},{"url":933},[50,60,55],{"type":405},{"pageTitle":1229,"pageDescription":1229},"\u002Fwork\u002Fbnt122-study.en",{"title":1229},"work\u002Fbnt122-study.en","lx38Hf5Y4ISB5tkGDy7fFwozAgqLq_zXtCmvkx29aco",{"id":1315,"title":1316,"body":78,"description":78,"extension":5,"meta":1317,"navigation":18,"path":1399,"seo":1400,"stem":1401,"__hash__":1402},"workPages\u002Fwork\u002Fbig-toe-trial.en.json","Big TOE Trial",{"pageTitle":1316,"pageMetadata":1318,"page_content":1321,"pageSocialShare":1398},{"htmlTitle":1319,"htmlDesc":1320},"Big TOE Trial | Big Toe Osteoarthritis Study | Morph","Morph created a Patient Information Tool and explainer animation in English and Welsh for the University of Warwick's Big TOE trial on big toe osteoarthritis.",[1322,1329,1335,1339,1345,1349,1356,1374,1397],{"type":85,"sectionSettings":1323,"settings":1324,"title":1325,"text":1326,"strapline":909,"image":1327},{"textAlign":87},{"imgPosition":89},"# Big TOE Trial","Big Toe OstEoarthritis trial.",{"url":1328,"width":94,"height":95},"bigtoe-work-header-2x.png",{"type":1059,"sectionSettings":1330,"maxLogosPerRow":129,"logos":1331},{"textAlign":87,"sectionLabel":1061},[1332,1333,1334],{"url":1064,"alt":381},{"url":1066,"alt":1067},{"url":1069,"alt":1070},{"type":355,"sectionSettings":1336,"textCol1":1337,"textCol2":1338},{"textAlign":87},"The Big TOE Trial is testing whether carbon fibre show inserts can reduce pain caused by osteoarthritis in the big toe joint.","Early childhood is when children begin learning to manage their emotions and behaviour, but some find this more challenging than others. The Healthy Start, Happy Start study evaluated a short, relationship-based programme where health visitors used video feedback to help parents better understand and respond to their child’s behaviour. The trial involved 300 families and found that children whose parents received the programme showed lower levels of behavioural problems, with benefits still visible years later.",{"type":97,"sectionSettings":1340,"settings":1341,"title":225,"text":1342,"image":1343},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"### Morph solution\n\n**Morph worked with the BigTOE Trial team to develop a digital Participant Information Tool and animation to support recruitment and help potential participants understand the study.**\n\n* Participant Information Tool (PIT) – a structured digital information tool that explains the study step by step. The tool introduces the condition, the purpose of the research and explains what taking part involves, allowing participants to explore the information at their own pace.\n* Explainer Animation – a short animation introducing big toe osteoarthritis and explaining how the BigTOE Trial is testing carbon fibre shoe inserts. The animation provides a simple overview of the research and helps people quickly understand the study and what participation involves.\n\nThe PIT and animation were produced in English and Welsh switchable by the user.",{"url":1344,"width":323,"height":324},"bigtoe-work-content-2x.png",{"type":221,"sectionSettings":1346,"settings":1347,"text":1348},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> Morph are great to work with. They really understand clinical trials and make an excellent end product\"\n\nAssociate Professor Mike Backhouse, University of Warwick",{"type":584,"sectionSettings":1350,"settings":1351,"video":1352,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":1353,"videoTitle":1354,"videoTranscript":1355},"1045433481?h=0d0a01d8a8","Big TOE Trial Animation","Osteoarthritis in the joint where the big toe joins the rest of the foot can hurt and cause the joint to become stiff and swollen. This is often worse when walking and can make it difficult to do your usual activities.\n\nThe BigToe trial is trying to find out whether special inserts that go inside your shoes can help people with painful big toe osteoarthritis.\n\nShoe inserts are commonly used to treat big toe osteoarthritis and can be made from different materials. We want to find out if using certain materials help people living with painful big toe osteoarthritis.\n\nIf you decide to take part you will be put in one of two groups. One group will use one type of shoe insert and the other group will use the other type. These shoe inserts look similar but are made with different materials.\n\nTo keep the trial fair neither you nor your healthcare provider can choose which group you will be in. There is an equal chance of receiving either shoe insert.\n\nYou will be given your own individual information about looking after your osteoarthritis including what types of shoes might help.\n\nThe trial has been designed to be as simple as possible. This means you won't need to come back for another appointment.\n\nWe will send you a short questionnaire five times over the next year asking you about your pain levels and general health.\n\nIf you'd like more information, please get in touch with the BigToe team who will be happy to help.",{"type":180,"sectionSettings":1357,"slides":1358},{"textAlign":87},[1359,1364,1369],{"narrowScreenImage":1360,"wideScreenImage":1362},{"url":1361,"width":186,"height":95},"bigtoe-work-slider-mobile-1-2x.png",{"url":1363,"width":189,"height":1190},"bigtoe-work-slider-desktop-1-2x.png",{"narrowScreenImage":1365,"wideScreenImage":1367},{"url":1366,"alt":225,"width":186,"height":95},"bigtoe-work-slider-mobile-2-2x.png",{"url":1368,"width":189,"height":95},"bigtoe-work-slider-desktop-2-2x.png",{"narrowScreenImage":1370,"wideScreenImage":1372},{"url":1371,"width":186,"height":95},"bigtoe-work-slider-mobile-3-2x.jpg",{"url":1373,"width":189,"height":95},"bigtoe-work-slider-desktop-3-2x.jpg",{"type":124,"sectionSettings":1375,"settings":1376,"text":1115,"cards":1377},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[1378,1385,1389,1393],{"type":134,"imgPosition":89,"strapline":696,"title":1379,"image":1380,"link":1382,"categories":1384},"CLEAR Study",{"url":1381,"width":139,"height":376},"morph-work-card-clear-2x.png",{"url":1383},"\u002Fwork\u002Fclear-study",[50,55],{"type":134,"imgPosition":89,"strapline":917,"title":918,"image":1386,"link":1387,"categories":1388,"summary":225},{"url":920,"width":139,"height":376},{"url":922},[50,55],{"type":134,"imgPosition":89,"strapline":1130,"title":1021,"image":1390,"link":1391,"categories":1392},{"url":1023},{"url":1025},[50,60,55],{"type":134,"imgPosition":89,"strapline":381,"title":382,"image":1394,"link":1395,"categories":1396,"summary":225},{"url":384,"width":139,"height":376},{"url":386},[50,60,55],{"type":405},{"pageTitle":1316,"pageDescription":1316},"\u002Fwork\u002Fbig-toe-trial.en",{"title":1316},"work\u002Fbig-toe-trial.en","LN9H3D4ZXaV4Et3fD-Ce0LZEQPp-YPhV2VFM-Uo1VKE",{"id":1404,"title":390,"body":78,"description":78,"extension":5,"meta":1405,"navigation":18,"path":1480,"seo":1481,"stem":1482,"__hash__":1483},"workPages\u002Fwork\u002Fc-gull-study.en.json",{"pageTitle":390,"pageMetadata":1406,"page_content":1409,"pageSocialShare":1478},{"htmlTitle":1407,"htmlDesc":1408},"C-GULL Study | Children's Health Cohort | Morph","Patient animations, a Patient Information Tool, and study website for the C-GULL childhood health and development cohort study at the University of Liverpool.",[1410,1417,1418,1422,1428,1432,1439,1457,1477],{"type":85,"sectionSettings":1411,"settings":1412,"title":1413,"text":1414,"strapline":389,"image":1415},{"textAlign":87},{"imgPosition":89},"# C-GULL Study","Children Growing Up in Liverpool (C-GULL) Study",{"url":1416,"width":94,"height":95},"cgull-work-header-2x.png",{"type":353},{"type":355,"sectionSettings":1419,"textCol1":1420,"textCol2":1421},{"textAlign":87},"The C-GULL  Study will be one of the largest longitudinal family studies in the UK - and the first in Liverpool.","The study is recruiting up to 10,000 families from across the Liverpool City Region to build a clearer picture of the health of children growing up in the area. Like many communities, children in Liverpool face health challenges including poverty, limited access to healthy food, and higher rates of childhood obesity. The region also has a higher prevalence of some long-term conditions, such as asthma and allergies.\n\nBy working with families, researchers and healthcare professionals hope to better understand these issues and develop strategies to improve children’s health and wellbeing.",{"type":97,"sectionSettings":1423,"settings":1424,"title":225,"text":1425,"image":1426},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"## Morph solution\n\n**We have supported the C-GULL Study from the outset, delivering our Study Solution alongside a range of additional print materials and animations.**\n\n* **Patient Information Animation** – an engaging animation that explained what participation in C-GULL involved, from pregnancy through childhood follow-up. Designed for parents and families, this animation helped build trust and confidence by showing the value of the study in a simple, reassuring way.\n* **Extra animations -** additional animations explaining key aspects of the study as they are introduced, plus shortened versions of the main animation for social channels\n* **Participant Information Tool (PIT)** – an interactive online tool that presented the patient information sheet in a step-by-step, accessible format. For C-GULL, this made it easier for parents-to-be to digest the details of long-term participation and supported truly informed consent.\n* **Study Website** – the central digital hub for C-GULL, providing families with clear, easy-to-navigate information about the study. It brought together the animations, PIT, and key details in one place, ensuring consistency and accessibility for participants across the Liverpool City Region.",{"url":1427,"width":323,"height":324},"cgull-work-content-2x.png",{"type":221,"sectionSettings":1429,"settings":1430,"text":1431},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> Morph's commitment to excellence is evident in every aspect of their work. They consistently demonstrate a remarkable level of professionalism, responsiveness, and attention to detail. Their ability to understand and translate complex clinical research concepts into visually appealing and easily understandable graphics and animations is truly commendable.\n\nDr. Christine Cornforth, Director of Partnerships & Programmes, The University of Liverpool.",{"type":584,"sectionSettings":1433,"settings":1434,"video":1435,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":1436,"videoTitle":1437,"videoTranscript":1438},"793037231?h=137a762fe2","C-GULL Study Animation","The Children Growing Up in Liverpool, C-GULL study, is tracking the health and wellbeing of children and their families in the Liverpool City Region.\n\nWe are collecting valuable information from 10,000 children and their families, starting in pregnancy and continuing throughout their lives. This type of study is called a longitudinal birth cohort.\n\nC-GULL is the first dedicated birth cohort in Liverpool. We are inviting all women aged 16 and over, pregnant with their first child, being cared for at Liverpool Women’s Hospital to take part. We want to involve all women and partners, where appropriate.\n\nTaking part is voluntary and you can change your mind and leave at any time. If you decide not to take part, you will still receive the normal standard of care. If you do decide to take part, you will be asked to sign a consent form.\n\nYou will be invited to visit the research centre at Liverpool Women’s Hospital between 12–16 weeks and 32–36 weeks of your pregnancy. At each visit you will see a research midwife and be asked some questions, have some measurements taken and give a small sample of blood, urine and hair. When you have your child we will also like to take a sample of your placenta and some of the blood from your child’s cord.\n\nShortly after birth we will ask if we can measure your baby’s body composition using a special incubator called a Pea Pod. This does not take long and should not cause any pain or discomfort to your baby.\n\nWe will contact you again when your baby is three months old and again at 12 months of age. At 24 months we will invite you back to the research centre with your toddler so that we can catch up with you and see how your baby is growing and developing.\n\nIn the future we will invite you to take part in follow-up assessments to discuss your child’s health and development. These assessments are voluntary.\n\nWe will also ask permission to request information from the NHS and other government departments. All information and samples collected as part of the study will be stored legally and securely. If you withdraw from the study no further samples or data will be collected.\n\nTaking part in this study will not put you or your baby at risk of harm and your normal maternity care will not be affected. Taking part will mean that your child’s development is tracked throughout their childhood, teenage years and beyond.\n\nWe believe that taking part in this study will help us to understand what can improve the lives and health of children and their families in the Liverpool City Region.\n\nIf you would like to take part or have any questions about this study, please contact a member of the research team.",{"type":180,"sectionSettings":1440,"slides":1441},{"textAlign":87},[1442,1447,1452],{"narrowScreenImage":1443,"wideScreenImage":1445},{"url":1444,"width":186,"height":95},"cgull-work-slider-mobile-1-2x.jpg",{"url":1446,"width":189,"height":95},"cgull-work-slider-desktop-1-2x.jpg",{"narrowScreenImage":1448,"wideScreenImage":1450},{"url":1449,"width":186,"height":95},"cgull-work-slider-mobile-2-2x.png",{"url":1451,"width":189,"height":95},"cgull-work-slider-desktop-2-2x.png",{"narrowScreenImage":1453,"wideScreenImage":1455},{"url":1454,"width":186,"height":95},"cgull-work-slider-mobile-3-2x.png",{"url":1456,"width":189,"height":95},"cgull-work-slider-desktop-3-2x.png",{"type":124,"sectionSettings":1458,"settings":1459,"text":1115,"cards":1460},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[1461,1465,1469,1473],{"type":134,"imgPosition":89,"strapline":381,"title":382,"image":1462,"link":1463,"categories":1464,"summary":225},{"url":384,"width":139,"height":376},{"url":386},[50,60,55],{"type":134,"imgPosition":89,"strapline":372,"title":689,"image":1466,"link":1467,"categories":1468},{"url":691,"width":139,"height":376},{"url":693},[50,65],{"type":134,"imgPosition":89,"strapline":372,"title":704,"image":1470,"link":1471,"categories":1472},{"url":845,"width":139,"height":376},{"url":708},[70,65,60],{"type":134,"imgPosition":89,"strapline":372,"title":929,"image":1474,"link":1475,"categories":1476},{"url":931,"width":139,"height":376},{"url":933},[50,60,55],{"type":405},{"pageTitle":1479,"pageDescription":1479},"Morph work - C-GULL Study","\u002Fwork\u002Fc-gull-study.en",{"title":390},"work\u002Fc-gull-study.en","vbC0Q-55KdjNCJ5_mXhuGz0IsG0z-Etya2ZlhzynZPM",{"id":1485,"title":1379,"body":78,"description":78,"extension":5,"meta":1486,"navigation":18,"path":1572,"seo":1573,"stem":1574,"__hash__":1575},"workPages\u002Fwork\u002Fclear-study.en.json",{"pageTitle":1379,"pageMetadata":1487,"page_content":1490,"pageSocialShare":1571},{"htmlTitle":1488,"htmlDesc":1489},"CLEAR Study | Cervical Screening Research | Morph","Patient and healthcare professional animations plus a multilingual website for the CLEAR cervical screening study at the University of the West of England.",[1491,1499,1505,1509,1515,1519,1526,1532,1550,1570],{"type":85,"sectionSettings":1492,"settings":1493,"title":1494,"text":1495,"strapline":1496,"image":1497},{"textAlign":87},{"imgPosition":89},"# CLEAR Study","Improving engagement and experience in cervical screening: implementing the left lateral test position","University of the West of England",{"url":1498,"width":94,"height":95},"clear-work-header-2x.png",{"type":1059,"sectionSettings":1500,"maxLogosPerRow":129,"logos":1501},{"textAlign":87,"sectionLabel":1061},[1502,1503,1504],{"url":1064,"alt":381},{"url":1066,"alt":1067},{"url":1069,"alt":1070},{"type":355,"sectionSettings":1506,"textCol1":1507,"textCol2":1508},{"textAlign":87},"The CLEAR Study aims to increase engagement with cervical screening and improve the experience of the test.","The study is exploring whether offering an alternative test position could make cervical screening more comfortable and encourage more people to attend. Cervical screening helps detect changes that can lead to cancer, but participation has declined in recent years, partly because some people find the traditional position uncomfortable.\n\nCLEAR is investigating how offering the option of a left-side test position might affect people’s comfort and experience, and how healthcare teams could introduce this choice into routine care.",{"type":97,"sectionSettings":1510,"settings":1511,"title":225,"text":1512,"image":1513},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"### Morph solution\n\n**For the CLEAR Study, we developed a patient-facing website and animation to present key information in a clear and accessible format. We also created a second animation to explain the process to clinicians.**\n\n* **Patient Information Website** – delivered as a single-page website. The site acts as a patient information resource, presenting high-level information in a simple and user-friendly way.\n* **Patient Information Animation** – a 2D explainer that explains the available screening options clearly and supports understanding ahead of an appointment.\n* **Healthcare Professional Animation** – an animation explaining the new screening approach and supporting clinicians introducing the left-side test position in practice.\n\nThe website and patient information animation are available in English, Polish, Urdu, Punjabi and Romanian, helping ensure accessibility for diverse communities.",{"url":1514,"width":323,"height":324},"clear-work-content-2x.png",{"type":221,"sectionSettings":1516,"settings":1517,"text":1518},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> We needed to present information to both patients and clinicians about positional choice in cervical screening, and it was essential that the animations were inclusive, sensitive, and clinically appropriate. The team at Morph fully understood this from the outset and delivered content that reflected those priorities with great care. They also translated the animations into four different languages, which has been very well received and has significantly broadened accessibility. \n\nDr Zoe Anchors, University of the West of England",{"type":584,"sectionSettings":1520,"settings":1521,"video":1522,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":1523,"videoTitle":1524,"videoTranscript":1525},"1116800438?h=f5ce4074e2","CLEAR Study Patient video","This short animation explains the different positions you can choose for a cervical screening test.\n\nEveryone is different.\n\nWe all have different bodies.\n\nAnd we all have different needs.\n\nBut everyone with a cervix over the age of 25, no matter what they look like or how they identify, is advised to go for cervical screening and not put it off.\n\nCervical screening is important because it can find a common virus that can cause changes in the cells of the cervix.\n\nIf these changes are not treated, they could turn into cancer later on.\n\nSome people feel embarrassed or worried about the test.\n\nThis might be because of negative experiences in the past, or because they think it will be uncomfortable.\n\nWe've learned that when people can make choices about how the test is done, they feel more in control and more at ease.\n\nDid you know you can now choose the position for your cervical screening test?\n\nYou can choose to lie on your back with your legs bent up and parted.\n\nOr you can lie on your left side with your legs slightly apart, resting on the bed.\n\nLying on your back might be physically difficult or cause anxiety.\n\nSome people find it more relaxing to lie on their side, which can help make the test feel more comfortable.\n\nAsk your doctor or nurse about your choice of positions before or during your appointment.\n\nThey will be able to guide you through the process.\n\nYour health is important, so we want your cervical screening to be as comfortable as possible.\n\nYou can choose what works best for you.",{"type":221,"sectionSettings":1527,"settings":1529,"text":1531},{"textAlign":126,"sectionLabel":678,"theme":1528},"mid",{"btnTheme":1530,"stackBtns":103},"secondary","> Working with Morph on our project was a very positive experience. The entire team was approachable, responsive, and easy to communicate with throughout the project. They responded promptly to queries and were highly receptive to feedback, particularly when adaptations were required following our Patient and Public Involvement (PPI) input.\n\nDr Zoe Anchors, University of the West of England",{"type":180,"sectionSettings":1533,"slides":1534},{"textAlign":87},[1535,1540,1545],{"narrowScreenImage":1536,"wideScreenImage":1538},{"url":1537,"width":186,"height":95},"clear-work-slider-mobile-1-2x.jpg",{"url":1539,"width":189,"height":95},"clear-work-slider-desktop-1-2x.jpg",{"narrowScreenImage":1541,"wideScreenImage":1543},{"url":1542,"width":186,"height":95},"clear-work-slider-mobile-2-2x.png",{"url":1544,"width":189,"height":95},"clear-work-slider-desktop-2-2x.png",{"narrowScreenImage":1546,"wideScreenImage":1548},{"url":1547,"width":186,"height":95},"clear-work-slider-mobile-3-2x.jpg",{"url":1549,"width":189,"height":95},"clear-work-slider-desktop-3-2x.jpg",{"type":124,"sectionSettings":1551,"settings":1552,"text":1115,"cards":1553},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[1554,1558,1562,1566],{"type":134,"imgPosition":89,"strapline":917,"title":918,"image":1555,"link":1556,"categories":1557,"summary":225},{"url":920,"width":139,"height":376},{"url":922},[50,55],{"type":134,"imgPosition":89,"strapline":909,"title":1316,"image":1559,"link":1560,"categories":1561,"summary":225},{"url":912,"width":139,"height":376},{"url":914},[50,55],{"type":134,"imgPosition":89,"strapline":1130,"title":1021,"image":1563,"link":1564,"categories":1565},{"url":1023},{"url":1025},[50,60,55],{"type":134,"imgPosition":89,"strapline":381,"title":382,"image":1567,"link":1568,"categories":1569,"summary":225},{"url":384,"width":139,"height":376},{"url":386},[50,60,55],{"type":405},{"pageTitle":1379,"pageDescription":1379},"\u002Fwork\u002Fclear-study.en",{"title":1379},"work\u002Fclear-study.en","v-xsknq6mQEagn0qs1LFrGKpwLr1FODVoH48zYpEiLA",{"id":1577,"title":849,"body":78,"description":78,"extension":5,"meta":1578,"navigation":18,"path":1653,"seo":1654,"stem":1655,"__hash__":1656},"workPages\u002Fwork\u002Fcrafft-trial.en.json",{"pageTitle":849,"pageMetadata":1579,"page_content":1582,"pageSocialShare":1651},{"htmlTitle":1580,"htmlDesc":1581},"CRAFFT Trial | Children's Wrist Fractures | Morph","Full communication package for the CRAFFT wrist fracture trial - patient animation, PIT, study website, and dissemination materials in five languages.",[1583,1590,1591,1595,1601,1605,1612,1630,1650],{"type":85,"sectionSettings":1584,"settings":1585,"title":1586,"text":1587,"strapline":372,"image":1588},{"textAlign":87},{"imgPosition":89},"# CRAFFT Trial","Children’s Radius Acute Fracture Fixation Trial.",{"url":1589,"width":94,"height":95},"crafft-work-header-2x.png",{"type":353},{"type":355,"sectionSettings":1592,"textCol1":1593,"textCol2":1594},{"textAlign":87},"The CRAFFT Study compared how best to treat broken wrists in children.","Led by the Oxford Trauma team, the trial compared whether treating a broken radius with a plaster cast alone was as effective as surgical intervention in children under 11 years old. The wrist is the most frequently broken bone in children, and previous evidence was limited on whether surgery provided better outcomes than casting alone.\n\nCRAFFT successfully recruited 750 children from centres across the UK, aiming to provide robust evidence to inform clinical practice and ensure that treatment decisions are both effective and appropriate for this age group.",{"type":97,"sectionSettings":1596,"settings":1597,"title":225,"text":1598,"image":1599},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"## Morph solution\n\n**Our solution for CRAFFT brought together a coordinated set of digital tools to support communication across recruitment, participation, and dissemination.**\n\n* **Patient Information Animation** – transformed the study’s Patient Information Sheet into a short 2D explainer, helping potential participants quickly understand what taking part involved.\n* **Patient Information Tool** – an interactive, step-by-step digital version of the patient information. Beginning with the animation, it presented study details in structured sections to support informed consent.\n* **Study Website** – a professional public-facing hub for the trial, featuring the animation and providing clear navigation with a direct link to the information tool.\n* **Dissemination Animation** – a concise 2D explainer presenting the study’s findings in a clear visual format.\n* **Dissemination Website** – a dedicated online home for the study results, bringing together the animation, publications, summaries, and key outputs in one accessible space.\n\nAll dissemination materials were produced in English and four additional languages, with language selection controlled by the user.",{"url":1600,"width":323,"height":324},"crafft-work-content-2x.png",{"type":221,"sectionSettings":1602,"settings":1603,"text":1604},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> “Working with the Morph team is great - I’ve worked with them over several studies, and they understand clinical research and what a study needs to be successful.\n\nProfessor Daniel Perry, Children's Orthopaedic Surgeon, University of Oxford",{"type":584,"sectionSettings":1606,"settings":1607,"video":1608,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":1609,"videoTitle":1610,"videoTranscript":1611},"378752967?h=b628ad2b8c","CRAFFT Trial video","\nThe CRAFFT study is trying to find out the best way to treat children who have broken their arm, and the bones have moved out of place. \n\nThe study is comparing the two most common treatments used throughout the UK. \n\nOne treatment is to put the arm in a plaster cast for four to six weeks. \n\nThere is evidence that children’s bones will naturally grow straight, though their arm may look a little bent for a few months, which can be distressing to some parents or children.\n\nHealing may take longer and in rare cases, an operation may be required. \n\nThe other treatment is to put the bones back into the right position first, before putting the arm in a plaster cast. \n\nChildren will be sedated or given a general anaesthetic so they can’t feel anything. \n\nSometimes a cut needs to be made in the arm to insert plates or wires to hold the bones in position. \n\nOccasionally the bone may move out of place or there may be an infection, both may require further treatment. \n\nIn the CRAFFT study, half the children will have their broken bone straighten naturally in a cast, and half will have their broken bone put back in position under sedation or during an operation.\n\nTo make things fair, the treatment will be decided using a computer. \n\nIf you join the CRAFFT study, we will ask you questions about how your child uses the arm, any pain they feel, and if they’ve missed any school. \n\nWe will send these questions by text message and or by e-mail. \n\nWe’ll ask you questions five times in the first year, then once a year for three years. \n\nThe doctors, nurses and research team are happy to answer any questions that you may have about joining the CRAFFT study.",{"type":180,"sectionSettings":1613,"slides":1614},{"textAlign":87},[1615,1620,1625],{"narrowScreenImage":1616,"wideScreenImage":1618},{"url":1617,"width":186,"height":95},"crafft-work-slider-mobile-1-2x.jpg",{"url":1619,"width":189,"height":95},"crafft-work-slider-desktop-1-2x.jpg",{"narrowScreenImage":1621,"wideScreenImage":1623},{"url":1622,"width":186,"height":95},"crafft-work-slider-mobile-2-2x.png",{"url":1624,"width":189,"height":95},"crafft-work-slider-desktop-2-2x.png",{"narrowScreenImage":1626,"wideScreenImage":1628},{"url":1627,"width":186,"height":95},"crafft-work-slider-mobile-3-2x.jpg",{"url":1629,"width":189,"height":1190},"crafft-work-slider-desktop-3-2x.jpg",{"type":124,"sectionSettings":1631,"settings":1632,"text":1115,"cards":1633},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[1634,1638,1642,1646],{"type":134,"imgPosition":89,"strapline":381,"title":382,"image":1635,"link":1636,"categories":1637,"summary":225},{"url":384,"width":139,"height":376},{"url":386},[50,60,55],{"type":134,"imgPosition":89,"strapline":372,"title":689,"image":1639,"link":1640,"categories":1641},{"url":691,"width":139,"height":376},{"url":693},[50,65],{"type":134,"imgPosition":89,"strapline":372,"title":704,"image":1643,"link":1644,"categories":1645},{"url":845,"width":139,"height":376},{"url":708},[70,65,60],{"type":134,"imgPosition":89,"strapline":1130,"title":1021,"image":1647,"link":1648,"categories":1649},{"url":1023},{"url":1025},[50,60,55],{"type":405},{"pageTitle":1652,"pageDescription":1652},"Morph work - CRAFFT Trial","\u002Fwork\u002Fcrafft-trial.en",{"title":849},"work\u002Fcrafft-trial.en","aElia1Udj66MMQsQGc7LM0XrjSkPC-aMcTr_jPzzXGw",{"id":1658,"title":689,"body":78,"description":78,"extension":5,"meta":1659,"navigation":18,"path":1734,"seo":1735,"stem":1736,"__hash__":1737},"workPages\u002Fwork\u002Fctt-study.en.json",{"pageTitle":689,"pageMetadata":1660,"page_content":1663,"pageSocialShare":1732},{"htmlTitle":1661,"htmlDesc":1662},"CTT Study | Cholesterol Research Dissemination | Morph","Morph produced a dissemination animation for the Cholesterol Treatment Trialists at the University of Oxford, communicating statin research to the public.",[1664,1671,1672,1676,1682,1686,1693,1711,1731],{"type":85,"sectionSettings":1665,"settings":1666,"title":1667,"text":1668,"strapline":372,"image":1669},{"textAlign":87},{"imgPosition":89},"# CTT Study","The Cholesterol Treatment Trialists’ (CTT) Collaboration conducted meta-analyses of cholesterol intervention trials.",{"url":1670,"width":94,"height":95},"ctt-work-header-2x.png",{"type":353},{"type":355,"sectionSettings":1673,"textCol1":1674,"textCol2":1675},{"textAlign":87},"The CTT Study was one of the largest meta-analyses of statin clinical trial data in the world.","Led by researchers at the University of Oxford, the Cholesterol Treatment Trialists’ (CTT) Collaboration analysed data from 23 randomised studies, including nearly 155,000 participants. Using this large combined dataset, the researchers examined the effects of statin treatment and assessed how often muscle-related symptoms were reported across different groups of patients. The findings were published in *The Lancet* in 2022, with a further CTT Collaboration paper published in 2026 building on this work.",{"type":97,"sectionSettings":1677,"settings":1678,"title":225,"text":1679,"image":1680},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"## Morph solution\n\n**The CTT project demonstrates how animation can provide a flexible and effective way to communicate research findings. The animation was designed to evolve alongside the study, with updates reflecting new data as results were published.**\n\n* **Dissemination Animation** – we produced a 2D explainer for the CTT Study, translating complex clinical data into a clear, visually engaging format. By highlighting the key findings and their implications, it enabled the Oxford Population Health team to share results effectively with both public and healthcare audiences.\n* **Animation Updates** – an initial version communicated the first round of findings. The animation was later updated when the final results were published in *The Lancet* in February 2026.",{"url":1681,"width":323,"height":324},"ctt-work-content-2x.png",{"type":221,"sectionSettings":1683,"settings":1684,"text":1685},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> **Morph have the creative knack of translating what can be tricky science into engaging animations that look fun and eye-catching. The animation has been really well-received by the audience.**\n\nSophia Wilkinson, Comms and Public Engagement, University of Oxford",{"type":584,"sectionSettings":1687,"settings":1688,"video":1689,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":1690,"videoTitle":1691,"videoTranscript":1692},"1158807383?h=0ea354ce16","CTT Dissemination Animation","As we get older, high levels of ‘bad cholesterol’ in our blood… can lead to fatty material building up in the walls of our arteries.\n\nThis can cause our arteries to become narrower or even blocked, stopping our blood flowing properly.\n\nIf this happens in our heart or brain, it can lead to a heart attack or stroke.\n\nThese can cause death or life-changing disability.\n\nA widely available and affordable type of medication, called statins can lower our levels of bad cholesterol.\n\nStatins have been tested in many clinical trials around the world.\n\nIn the highest quality trials large numbers of volunteers were randomly split into two groups one given a statin tablet and the other a matching dummy tablet, called a placebo.\n\nThen scientists compared the health of each group over a period of years.\n\nAs neither group, nor clinical trial staff, knew which type of tablet they had been given the comparison between the groups was as fair as possible.\n\nThe results showed that statins are really effective at reducing heart attacks and strokes and that the benefits of taking them hugely outweigh any risks.\n\nHowever, concerns about possible side effects have led some people to stop taking statins or decide against starting them. \n\nTo find out if this is really the case, a group of researchers looked at all the information from these high-quality big clinical trials.\n\nThey organised millions of pieces of information, from around 155,000 trial participants into a database.\n\nThen they searched statin packaging leaflets for reports of medical problems listed as potential side effects to see if it made any difference whether people had taken the statins or the placebo.\n\nThe researchers found that memory loss or dementia, depression sleep disturbance, erectile dysfunction, weight gain, nausea, fatigue or headache and nearly all the other conditions listed as potential side effects occurred just as often in people taking the placebo as in those taking statins. \n\nFor example, each year the number of reports of memory impairment was 0.2% in those taking the statins, but also 0.2% in those taking the placebo.\n\nThis means that while people may notice these symptoms whilst taking statins there is now good evidence that they are not caused by the statin.\n\nThere was a very small increase in risk — about 0.1% in abnormal liver blood test results but no increase in serious liver conditions.\n\nWe already knew that almost all muscle problems, over 90%, are not caused by statins at all.\n\nThe very small number of muscle problems that were caused by a statin were generally mild and mainly occurred in the first year of treatment.\n\nStatins can slightly increase the chance of developing diabetes mainly in those already at higher risk.\n\nTaken together with what we already knew the new findings show that statins do not cause most of the possible side effects listed in the packaging leaflets.\n\nStatins reduce your risk of having a heart attack or a stroke and the benefits increase if the treatment is taken for a number of years.\n\nFor most people, the benefits of statins will hugely outweigh any potential side effects.\n\n\n",{"type":180,"sectionSettings":1694,"slides":1695},{"textAlign":87},[1696,1701,1706],{"narrowScreenImage":1697,"wideScreenImage":1699},{"url":1698,"width":186,"height":95},"ctt-work-slider-mobile-1-2x.png",{"url":1700,"width":189,"height":95},"ctt-work-slider-desktop-1-2x.png",{"narrowScreenImage":1702,"wideScreenImage":1704},{"url":1703,"width":186,"height":95},"ctt-work-slider-mobile-2-2x.png",{"url":1705,"width":189,"height":95},"ctt-work-slider-desktop-2-2x.png",{"narrowScreenImage":1707,"wideScreenImage":1709},{"url":1708,"width":186,"height":95},"ctt-work-slider-mobile-3-2x.png",{"url":1710,"width":189,"height":95},"ctt-work-slider-desktop-3-2x.png",{"type":124,"sectionSettings":1712,"settings":1713,"text":1115,"cards":1714},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[1715,1719,1723,1727],{"type":134,"imgPosition":89,"strapline":372,"title":689,"image":1716,"link":1717,"categories":1718},{"url":691,"width":139,"height":376},{"url":693},[50,65],{"type":134,"imgPosition":89,"strapline":372,"title":704,"image":1720,"link":1721,"categories":1722},{"url":845,"width":139,"height":376},{"url":708},[70,65,60],{"type":134,"imgPosition":89,"strapline":397,"title":711,"image":1724,"link":1725,"categories":1726},{"url":400},{"url":402},[50,65],{"type":134,"imgPosition":89,"strapline":372,"title":849,"image":1728,"link":1729,"categories":1730},{"url":851,"width":139,"height":376},{"url":772},[60],{"type":405},{"pageTitle":1733,"pageDescription":1733},"Morph work - CTT Study","\u002Fwork\u002Fctt-study.en",{"title":689},"work\u002Fctt-study.en","SmwpWedIpgpKkowshrGUIcwn0joIm1xNaiulOH42YbA",{"id":1739,"title":1740,"body":78,"description":78,"extension":5,"meta":1741,"navigation":18,"path":1823,"seo":1824,"stem":1825,"__hash__":1826},"workPages\u002Fwork\u002Fd-mapp-study.en.json","D-MAPP Study",{"pageTitle":1740,"pageMetadata":1742,"page_content":1745,"pageSocialShare":1822},{"htmlTitle":1743,"htmlDesc":1744},"D-MAPP Study | Digital Pain Management | Morph","Morph built the D-MAPP app - a digital self-management tool for arm, wrist, and hand pain from the University of Leeds - along with explainer animations.",[1746,1753,1759,1763,1769,1773,1780,1798,1821],{"type":85,"sectionSettings":1747,"settings":1748,"title":1749,"text":1750,"strapline":1070,"image":1751},{"textAlign":87},{"imgPosition":89},"# D-MAPP Study","Digital Management of Arm Pain Programme.",{"url":1752,"width":94,"height":95},"dmapp-work-header-2x.png",{"type":1059,"sectionSettings":1754,"maxLogosPerRow":129,"logos":1755},{"textAlign":87,"sectionLabel":1061},[1756,1757,1758],{"url":1064,"alt":381},{"url":1066,"alt":1067},{"url":1069,"alt":1070},{"type":355,"sectionSettings":1760,"textCol1":1761,"textCol2":1762},{"textAlign":87},"The D-MAPP Study is evaluating a digital self-management programme to support people with arm, wrist and hand pain.","Distal upper limb musculoskeletal disorders — affecting areas such as the elbow, wrist and hand — are common and can impact work and everyday activities. The D-MAPP (Digital Management of Arm Pain Programme) study is investigating whether a digital intervention can help people better manage these conditions. Co-designed with patients, clinicians and researchers, the programme combines education, exercises and behaviour change support to encourage adherence and improve symptom management over time.",{"type":97,"sectionSettings":1764,"settings":1765,"title":225,"text":1766,"image":1767},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"## Morph solution\n\n**Morph designed and developed the D-MAPP digital programme in collaboration with the research team. In this project, our role extended beyond communication materials to building the digital intervention itself.**\n\n* **D-MAPP App** — a bespoke digital platform delivering structured self-management support for people experiencing arm pain. Developed through a co-design process with patients, clinicians and researchers, the app provides guidance, exercises and educational content through a clear and accessible interface. The programme incorporates behaviour change principles to encourage engagement and adherence to treatment, allowing participants to work through the content at their own pace.\n* **In-app Explainer Animations** — a series of short animations integrated within the app to explain how the exercises and management strategies work. These were tailored to specific patient groups, including conditions such as tennis elbow and carpal tunnel syndrome, helping users understand how to complete the exercises safely and manage their symptoms more effectively.",{"url":1768,"width":323,"height":324},"dmapp-work-content-2x.png",{"type":221,"sectionSettings":1770,"settings":1771,"text":1772},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> **Working with Morph has been an excellent experience. Their combination of thoughtful design, clear guidance, and strong technical expertise helped us build a user‑friendly digital healthcare app that will make a real difference for patients. We’re really pleased with the outcome and would happily collaborate with them again.**\n\nJo Rimmer, Research Programme Manager, University of Leeds",{"type":584,"sectionSettings":1774,"settings":1775,"video":1776,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":1777,"videoTitle":1778,"videoTranscript":1779},"975087438?h=168223b89e","D-MAPP in-app Animation ","Welcome to your personal physio program. Your program has been designed by clinical experts in your condition. Start today on your 12 week daily exercise plan.\n\nAfter each exercise session, tell us how it felt. Was it too easy or too challenging? We'll adjust your next session to make sure that your program is always right for you. Track your progress, celebrate your achievements, and see the positive changes on those tough days.\n\nUse our difficult day feature to lighten the load. Doing something is always better than doing nothing. We know physio exercises improve symptoms for people with your condition. So every exercise, every session is a step towards improvement. Start your journey to better health today.",{"type":180,"sectionSettings":1781,"slides":1782},{"textAlign":87},[1783,1788,1793],{"narrowScreenImage":1784,"wideScreenImage":1786},{"url":1785,"width":186,"height":95},"dmapp-work-slider-mobile-1-2x.png",{"url":1787,"width":189,"height":95},"dmapp-work-slider-desktop-1-2x.png",{"narrowScreenImage":1789,"wideScreenImage":1791},{"url":1790,"width":186,"height":95},"dmapp-work-slider-mobile-2-2x.jpg",{"url":1792,"width":189,"height":95},"dmapp-work-slider-desktop-2-2x.jpg",{"narrowScreenImage":1794,"wideScreenImage":1796},{"url":1795,"width":186,"height":95},"dmapp-work-slider-mobile-3-2x.png",{"url":1797,"width":189,"height":95},"dmapp-work-slider-desktop-3-2x.png",{"type":124,"sectionSettings":1799,"settings":1800,"text":1115,"cards":1801},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[1802,1809,1813,1817],{"type":134,"imgPosition":89,"strapline":696,"title":1803,"image":1804,"link":1806,"categories":1808},"SURGE Study",{"url":1805,"width":139,"height":376},"morph-work-card-surge-2x.png",{"url":1807},"\u002Fwork\u002Fsurge-study",[50,60],{"type":134,"imgPosition":89,"strapline":696,"title":1379,"image":1810,"link":1811,"categories":1812},{"url":1381,"width":139,"height":376},{"url":1383},[50,55],{"type":134,"imgPosition":89,"strapline":389,"title":390,"image":1814,"link":1815,"categories":1816},{"url":392,"width":139,"height":376},{"url":394},[55,50,60],{"type":134,"imgPosition":89,"strapline":381,"title":382,"image":1818,"link":1819,"categories":1820,"summary":225},{"url":384,"width":139,"height":376},{"url":386},[50,60,55],{"type":405},{"pageTitle":1740,"pageDescription":1740},"\u002Fwork\u002Fd-mapp-study.en",{"title":1740},"work\u002Fd-mapp-study.en","WwLLmgNJUyDShbReURIXRjcC_qGVT84ywDYKZClbuic",{"id":1828,"title":382,"body":78,"description":78,"extension":5,"meta":1829,"navigation":18,"path":1909,"seo":1910,"stem":1911,"__hash__":1912},"workPages\u002Fwork\u002Felsa-study.en.json",{"pageTitle":382,"pageMetadata":1830,"page_content":1833,"pageSocialShare":1907},{"htmlTitle":1831,"htmlDesc":1832},"ELSA Study | Type 1 Diabetes Screening | Morph","Morph's long-term collaboration with the University of Birmingham on ELSA - producing animations, a Patient Information Tool, and study website for the trial.",[1834,1841,1847,1851,1857,1861,1868,1886,1906],{"type":85,"sectionSettings":1835,"settings":1836,"title":1837,"text":1838,"strapline":381,"image":1839},{"textAlign":87},{"imgPosition":89},"# ELSA Study","Early Surveillance for Autoimmune diabetes study",{"url":1840,"width":94,"height":95},"elsa-work-header-2x.png",{"type":1059,"sectionSettings":1842,"maxLogosPerRow":129,"logos":1843},{"textAlign":87,"sectionLabel":1061},[1844,1845,1846],{"url":1064,"alt":381},{"url":1066,"alt":1067},{"url":1069,"alt":1070},{"type":355,"sectionSettings":1848,"textCol1":1849,"textCol2":1850},{"textAlign":87},"The ELSA Study is the largest type1 diabetes screening programme for children in the UK.","ELSA initially launched in the West Midlands as a regional feasibility study, it has since expanded into a nationwide programme. Results from the first phase show that screening is both feasible and acceptable, with tens of thousands of families taking part.\n\nBy identifying children at higher risk of developing type 1 diabetes before symptoms appear, the programme aims to reduce emergency diagnoses and give families more time to understand and manage the condition.",{"type":97,"sectionSettings":1852,"settings":1853,"title":225,"text":1854,"image":1855},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"## Morph solution\n\n**We have worked with the ELSA team over several years, supporting the programme as it expanded in scale and scope. As new phases were introduced and the target age range widened, communication materials were refined to ensure they remained clear, age-appropriate, and engaging for children and their families.**\n\n* **Patient Information Animations** — a series of clear, easy-to-follow animations explaining what participation in each phase involved. Designed to be accessible to both parents and children, they helped families understand screening and reduced anxiety around taking part.\n* **Extra Animations** - we produced additional animations to communicate key information, including guidance on home testing \n* **Participant Information Tool (PIT)** — an interactive digital version of the patient information sheet, guiding families step by step through key details. Combining animation and structured written content, it supported informed decision-making across a large national participant base and was updated as the programme developed.\n* **Study Website** — developed as the central hub for ELSA, bringing together all key materials in one accessible space. As the study progressed, the site expanded to reflect new phases and age groups, maintaining a consistent and family-friendly experience throughout.",{"url":1856,"width":323,"height":324},"elsa-work-content-2x.png",{"type":221,"sectionSettings":1858,"settings":1859,"text":1860},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> **The ELSA website has even been used as a case study by the Clinical Research Network as a good example of a study site!**\n>\n> **An overwhelmingly positive aspect has been the website. All families have commented on how clear and easy to use it is. A few have commented on the quality of the infographics and videos  shown to their children.** \n>\n> **We wanted to thank you for supporting the success of the ELSA study!**\n\nDr Lauren Quinn, University of Birmingham",{"type":584,"sectionSettings":1862,"settings":1863,"video":1864,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":1865,"videoTitle":1866,"videoTranscript":1867},"1152365631?h=f2a799e4a1","The ELSA Study Animation","The ElSA study is testing a type one diabetes screening program for children and young adults.\n\nWe want to find out whether a simple blood test can tell us whether your child is likely to develop type one diabetes in the future.\n\nThis information will allow us to start treatment sooner.\n\nDiabetes is a serious, lifelong condition.\n\nThere are two main types of diabetes.\n\nType two diabetes is caused by a combination of genetic and lifestyle factors and is less common in children.\n\nType one diabetes is caused by the body's own immune system destroying the pancreas and organ in the body that produces insulin.\n\nInsulin is a natural hormone needed by your body to convert glucose into the energy needed for everyday life.\n\nChildren who develop Type one diabetes can become extremely unwell and need to take insulin straight away and continue for the rest of their lives.\n\nIf diabetes is not managed properly, it can lead to increased health risks.\n\nAround the world research studies are identifying children at high risk of developing Type one diabetes.\n\nThere are many advantages to knowing if your child is at risk.\n\nThese include identifying Type one diabetes earlier so that children can be started on treatment sooner and do not get too unwell.\n\nThe Elsa study is screening children age two to 17 years for type one diabetes.\n\nTaking part involves a simple finger stick blood test.\n\nYou can choose to do the test at home, at school, at your doctors, or in community centres near you.\n\nIf the test is negative your child will not need any more tests in the ELSA study. \n\nIf the test is positive your child will be invited to come to the hospital to have some more tests to confirm if your child is at high risk.\n\nWe understand it may be distressing for the family to find out that your child is at risk of developing type one diabetes.\n\nThe ELSA study team are here to support families with this information.\n\nYour family will be invited to an education session so we can explain what this risk means for your child's future and what the available options are.\n\nFor example, you can choose to enter your child into a monitoring program so we can do more regular checkups and we'll let you know about studies that may help delay the start of type one diabetes.\n\nEvery family who takes part in the ELSA study will be helping us to understand more about type one diabetes.\n\nIf you would like to take part in the ELSA study or find out more information, please visit our website or contact the ElSA study team.\n\nThank you.\n",{"type":180,"sectionSettings":1869,"slides":1870},{"textAlign":87},[1871,1876,1881],{"narrowScreenImage":1872,"wideScreenImage":1874},{"url":1873,"width":186,"height":95},"elsa-work-slider-mobile-1-2x.jpg",{"url":1875,"width":189,"height":95},"elsa-work-slider-desktop-1-2x.jpg",{"narrowScreenImage":1877,"wideScreenImage":1879},{"url":1878,"width":186,"height":95},"elsa-work-slider-mobile-2-2x.png",{"url":1880,"width":189,"height":95},"elsa-work-slider-desktop-2-2x.png",{"narrowScreenImage":1882,"wideScreenImage":1884},{"url":1883,"width":186,"height":95},"elsa-work-slider-mobile-3-2x.jpg",{"url":1885,"width":189,"height":95},"elsa-work-slider-desktop-3-2x.jpg",{"type":124,"sectionSettings":1887,"settings":1888,"text":1115,"cards":1889},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[1890,1894,1898,1902],{"type":134,"imgPosition":89,"strapline":389,"title":390,"image":1891,"link":1892,"categories":1893},{"url":392,"width":139,"height":376},{"url":394},[55,50,60],{"type":134,"imgPosition":89,"strapline":372,"title":929,"image":1895,"link":1896,"categories":1897},{"url":931,"width":139,"height":376},{"url":933},[50,60,55],{"type":134,"imgPosition":89,"strapline":1130,"title":1021,"image":1899,"link":1900,"categories":1901},{"url":1023},{"url":1025},[50,60,55],{"type":134,"imgPosition":89,"strapline":372,"title":704,"image":1903,"link":1904,"categories":1905},{"url":845,"width":139,"height":376},{"url":708},[70,65,60],{"type":405},{"pageTitle":1908,"pageDescription":1908},"Morph work - ELSA Study","\u002Fwork\u002Felsa-study.en",{"title":382},"work\u002Felsa-study.en","f_txmlHAsyLqD1JRmhXqu3ITOM4Ry9qE9VuUQDjgMPk",{"id":1914,"title":697,"body":78,"description":78,"extension":5,"meta":1915,"navigation":18,"path":1994,"seo":1995,"stem":1996,"__hash__":1997},"workPages\u002Fwork\u002Ffrontier-study.en.json",{"pageTitle":697,"pageMetadata":1916,"page_content":1919,"pageSocialShare":1993},{"htmlTitle":1917,"htmlDesc":1918},"FRONTIER Study | Physiotherapy Research | Morph","Two explainer animations for the FRONTIER study on First Contact Physiotherapy - for patients and stakeholders - at the University of the West of England.",[1920,1927,1933,1937,1943,1947,1954,1972,1992],{"type":85,"sectionSettings":1921,"settings":1922,"title":1923,"text":1924,"strapline":1496,"image":1925},{"textAlign":87},{"imgPosition":89},"# FRONTIER Study","First Contact Physiotherapy in Primary Care.",{"url":1926,"width":94,"height":95},"frontier-work-header-2x.png",{"type":1059,"sectionSettings":1928,"maxLogosPerRow":129,"logos":1929},{"textAlign":87,"sectionLabel":1061},[1930,1931,1932],{"url":1064,"alt":381},{"url":1066,"alt":1067},{"url":1069,"alt":1070},{"type":355,"sectionSettings":1934,"textCol1":1935,"textCol2":1936},{"textAlign":87},"The FRONTIER Study is exploring how First Contact Physiotherapy works in general practice.","First Contact Physiotherapy (FCP) allows patients with musculoskeletal problems to see an experienced physiotherapist as their first point of contact in a GP practice. The FRONTIER Study is investigating the clinical impact, patient outcomes and costs of this approach, helping to understand how FCP can support primary care services and improve access to appropriate treatment.",{"type":97,"sectionSettings":1938,"settings":1939,"title":225,"text":1940,"image":1941},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"### Morph solution\n\n**Morph produced a pair of dissemination animations to help communicate the findings of the FRONTIER Study to different audiences.**\n\n* **Explainer Animation (patient version)** — a patient-facing animation designed to run on screens in GP waiting rooms. As TV screens in these environments often operate without sound, the animation was designed to work clearly without audio, with on-screen text integrated into the visual design.\n* **Explainer Animation (stakeholder version)** — a second animation created for GP practice managers and healthcare stakeholders. This version explained the benefits of First Contact Physiotherapists and helped communicate the study findings to those involved in delivering primary care services.",{"url":1942,"width":323,"height":324},"frontier-work-content-2x.png",{"type":221,"sectionSettings":1944,"settings":1945,"text":1946},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> **We have worked with morph multiple times now, have recommended them to others and would not hesitate to partner with them again in the future.**\n\nProfessor Nicola Walsh, University of the West of England",{"type":584,"sectionSettings":1948,"settings":1949,"video":1950,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":1951,"videoTitle":1952,"videoTranscript":1953},"956515454?h=c2ccdb67e6","FRONTIER Study Patient Animation","Musculoskeletal conditions such as back, neck and joint pain are one of the most common reasons people visit their GP.\n\nIn many GP practices, patients can now see a First Contact Physiotherapist instead.\n\nFirst Contact Physiotherapists are highly trained specialists in musculoskeletal conditions.\n\nThey can assess, diagnose and help manage problems affecting muscles, joints and bones.\n\nSeeing a First Contact Physiotherapist first can help patients get the right advice and treatment sooner.\n\nIt can also help reduce pressure on GP appointments.\n\nThe FRONTIER Study is investigating the impact of First Contact Physiotherapists in primary care.\n\nResearchers are looking at how this approach affects patient outcomes, healthcare use and costs.\n\nThe study is working with GP practices across the UK.\n\nBy understanding how First Contact Physiotherapy works in practice, the study aims to support decisions about how services are delivered in the future.",{"type":180,"sectionSettings":1955,"slides":1956},{"textAlign":87},[1957,1962,1967],{"narrowScreenImage":1958,"wideScreenImage":1960},{"url":1959,"width":186,"height":95},"frontier-work-slider-mobile-1-2x.png",{"url":1961,"width":189,"height":95},"frontier-work-slider-desktop-1-2x.png",{"narrowScreenImage":1963,"wideScreenImage":1965},{"url":1964,"width":186,"height":95},"frontier-work-slider-mobile-2-2x.png",{"url":1966,"width":189,"height":95},"frontier-work-slider-desktop-2-2x.png",{"narrowScreenImage":1968,"wideScreenImage":1970},{"url":1969,"width":186,"height":95},"frontier-work-slider-mobile-3-2x.png",{"url":1971,"width":189,"height":95},"frontier-work-slider-desktop-3-2x.png",{"type":124,"sectionSettings":1973,"settings":1974,"text":1115,"cards":1975},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[1976,1980,1984,1988],{"type":134,"imgPosition":89,"strapline":372,"title":689,"image":1977,"link":1978,"categories":1979},{"url":691,"width":139,"height":376},{"url":693},[50,65],{"type":134,"imgPosition":89,"strapline":372,"title":704,"image":1981,"link":1982,"categories":1983},{"url":845,"width":139,"height":376},{"url":708},[70,65,60],{"type":134,"imgPosition":89,"strapline":397,"title":711,"image":1985,"link":1986,"categories":1987},{"url":400},{"url":402},[50,65],{"type":134,"imgPosition":89,"strapline":372,"title":849,"image":1989,"link":1990,"categories":1991},{"url":851,"width":139,"height":376},{"url":772},[60],{"type":405},{"pageTitle":697,"pageDescription":697},"\u002Fwork\u002Ffrontier-study.en",{"title":697},"work\u002Ffrontier-study.en","-OlYBeegW5y9q7w59z17hElAassp8d_hXRh6JH-g1-k",{"id":1999,"title":2000,"body":78,"description":78,"extension":5,"meta":2001,"navigation":18,"path":2059,"seo":2060,"stem":2061,"__hash__":2062},"workPages\u002Fwork\u002Fhelp-trial.en.json","HELP Trial",{"pageTitle":2000,"pageMetadata":2002,"page_content":2005,"pageSocialShare":2057},{"htmlTitle":2003,"htmlDesc":2004},"HELP Trial | Hysteroscopy for Infertility | Morph","Morph created a Patient Information Animation for the University of Sheffield's HELP trial examining hysteroscopic treatment for recurrent miscarriage.",[2006,2014,2015,2019,2025,2029,2035,2056],{"type":85,"sectionSettings":2007,"settings":2008,"title":2009,"text":2010,"strapline":2011,"image":2012},{"textAlign":87},{"imgPosition":89},"# HELP Trial","Hysteroscopic Excision of Leiomyoma and Polyp in Infertility.","University of Sheffield",{"url":2013,"width":94,"height":95},"morph-header-image 5@2x.png",{"type":353},{"type":355,"sectionSettings":2016,"textCol1":2017,"textCol2":2018},{"textAlign":87},"A national study exploring whether removing small growths in the womb can improve the chances of having a baby for women who have experienced infertility or repeated miscarriage.","The HELP Fertility study is assessing whether hysteroscopic removal of submucous fibroids or endometrial polyps can improve birth outcomes in women experiencing infertility or recurrent miscarriage. The study is also evaluating whether this approach is clinically effective and cost effective compared with no hysteroscopic removal.",{"type":97,"sectionSettings":2020,"settings":2021,"title":225,"text":2022,"image":2023},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"## Morph solution\n\n* **Patient Information Animation** - We worked with the team from the School of Health and Related Research at The University of Sheffield to produce this animation. The animation will be used as part of the process to inform potential participants and provide them with enough information to decide whether or not to take part.",{"url":2024,"width":323,"height":324},"morph-content-image 1@2x.png",{"type":221,"sectionSettings":2026,"settings":2027,"text":2028},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> Morph were extremely knowledgeable about clinical trial processes and were able to tailor their advice to fit the brief perfectly. They were responsive and flexible, and managed to create a video that the whole team is proud of.” \n\nAmy Barr, Clinical Trials Research Unit, University of Sheffield",{"type":584,"sectionSettings":2030,"settings":2031,"video":2032,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":2033,"videoTitle":1691,"videoTranscript":2034},"1158807383","As we get older, high levels of ‘bad cholesterol’ in our blood… can lead to fatty material… building up in the walls of our arteries.\n\nThis can cause our arteries to become narrower or even blocked, stopping our blood flowing properly.\n\nIf this happens in our heart or brain, it can lead to a heart attack or stroke.\n\nThese can cause death or life-changing disability.\n\nA widely available and affordable type of medication, called statins can lower our levels of bad cholesterol.\n\nStatins have been tested in many clinical trials around the world.\n\nIn the highest quality trials large numbers of volunteers were randomly split into two groups… one given a statin tablet and the other a matching dummy tablet, called a placebo.\n\nThen scientists compared the health of each group over a period of years.\n\nAs neither group, nor clinical trials staff, knew which type of tablet they had been given… the comparison between the groups was as fair as possible.\n\nThe results showed that statins are really effective at reducing heart attacks and strokes and that the benefits of taking them hugely outweigh any risks.\n\nHowever, concerns about possible side effects have led some people to stop taking statins or decide against starting them. \n\nTo find out if this is really the case, a group of researchers looked at all the information from these high-quality big clinical trials.\n\nThey organised millions of pieces of information from around 155,000 trial participants into a database.\n\nThen they searched statin packaging leaflets for reports of medical problems listed as potential side effects to see if it made any difference whether people had taken the statins or the placebo.\n\nThe researchers found that memory loss or dementia, depression sleep disturbance, erectile dysfunction weight gain, nausea fatigue or headache and nearly all the other conditions listed as potential side effects occurred just as often in people taking the placebo as in those taking statins. \n\nFor example, each year the number of reports of memory impairment was 0.2% in those taking the statins, but also 0.2% in those taking the placebo.\n\nThis means that while people may notice these symptoms whilst taking statins… there is now good evidence that they arenot caused by the statin.\n\nThere was a very small increase in risk — about 0.1% — in abnormal liver blood test results, but no increase in serious liver conditions.\n\nWe already knew that almost all muscle problems, over 90%, are not caused by statins at all.\n\nThe very small number of muscle problems that were caused by a statin were generally mild and mainly occurred in the first year of treatment.\n\nStatins can slightly increase the chance of developing diabetes mainly in those already at higher risk.\n\nTaken together with what we already knew the new findings show that statins do not cause most of the possible side effects listed in the packaging leaflets.\n\nStatins reduce your risk of having a heart attack or a stroke and the benefits increase if the treatment is taken for a number of years.\n\nFor most people, the benefits of statins will hugely outweigh any potential side effects.",{"type":124,"sectionSettings":2036,"settings":2037,"text":1115,"cards":2038},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[2039,2043,2047,2052],{"type":134,"imgPosition":89,"strapline":372,"title":373,"summary":225,"image":2040,"link":2041,"categories":2042},{"url":375,"width":139,"height":376},{"url":378},[50],{"type":134,"imgPosition":89,"strapline":372,"title":689,"image":2044,"link":2045,"categories":2046},{"url":780,"width":139,"height":376},{"url":693},[50,65],{"type":134,"imgPosition":89,"strapline":372,"title":849,"image":2048,"link":2050,"categories":2051},{"url":2049,"width":139,"height":376},"morph-work-card-image 2@2x.png",{"url":772},[60],{"type":134,"imgPosition":89,"strapline":372,"title":704,"image":2053,"link":2054,"categories":2055},{"url":706,"width":139,"height":376},{"url":708},[70,65,60],{"type":405},{"pageTitle":2058,"pageDescription":2058},"Morph work - HELP Trial","\u002Fwork\u002Fhelp-trial.en",{"title":2000},"work\u002Fhelp-trial.en","U78Fk8EpZYl5QxIcBcc9KgwkmW6sR_U4hju83Ihidz4",{"id":2064,"title":711,"body":78,"description":78,"extension":5,"meta":2065,"navigation":18,"path":2144,"seo":2145,"stem":2146,"__hash__":2147},"workPages\u002Fwork\u002Fhealthy-start-happy-start.en.json",{"pageTitle":711,"pageMetadata":2066,"page_content":2069,"pageSocialShare":2143},{"htmlTitle":2067,"htmlDesc":2068},"Healthy Start, Happy Start | Parenting Research | Morph","A dissemination animation sharing results from the Healthy Start, Happy Start parenting intervention study at the University of the West of England.",[2070,2077,2083,2086,2092,2096,2103,2121,2142],{"type":85,"sectionSettings":2071,"settings":2072,"title":2073,"text":2074,"strapline":1496,"image":2075},{"textAlign":87},{"imgPosition":89},"# Healthy Start, Happy Start Study","A video-feedback parenting programme to prevent early childhood behavioural problems.",{"url":2076,"width":94,"height":95},"healthy-happy-work-header-2x.png",{"type":1059,"sectionSettings":2078,"maxLogosPerRow":129,"logos":2079},{"textAlign":87,"sectionLabel":1061},[2080,2081,2082],{"url":1064,"alt":381},{"url":1066,"alt":1067},{"url":1069,"alt":1070},{"type":355,"sectionSettings":2084,"textCol1":2085,"textCol2":1338},{"textAlign":87},"The Healthy Start, Happy Start Study tested a parenting programme designed to support families with toddlers showing early signs of behavioural difficulties.",{"type":97,"sectionSettings":2087,"settings":2088,"title":225,"text":2089,"image":2090},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"### Morph solution\n\n**Morph produced a dissemination animation for the Healthy Start, Happy Start study to communicate the trial findings in a clear and accessible way.**\n\n* **Dissemination Animation** — a concise 2D explainer presenting the key results of the study and what they mean for families, practitioners and policymakers. The animation translated complex research findings into a clear visual narrative, helping the research team share the impact of the programme more widely across professional and public audiences.",{"url":2091,"width":323,"height":324},"healthy-happy-work-content-2x.png",{"type":221,"sectionSettings":2093,"settings":2094,"text":2095},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> Our team think the animation is brilliant – it was even better than we hoped. Morph has been a great partner working with the research teams from Imperial College London Trials Unit and the University of Cambridge.\n\nProfessor Christine O’Farrelly, University of Cambridge",{"type":584,"sectionSettings":2097,"settings":2098,"video":2099,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":2100,"videoTitle":2101,"videoTranscript":2102},"1017004009?h=13af3fa783?ts=7317","Healthy Start Happy Start Animation","All children have tantrums sometimes. But when behaviour problems start early in life they can have a big impact on families.\n\nParents often want practical support to help manage difficult behaviour and build positive relationships with their children.\n\nThe Healthy Start, Happy Start study tested a short parenting programme designed to support families with young children showing early signs of behavioural difficulties.\n\nThe programme used video feedback to help parents understand their child’s behaviour and recognise positive interactions.\n\nParents were filmed playing with their child and then reviewed the footage with a trained practitioner.\n\nTogether they identified moments that showed positive communication and explored ways to build on these interactions.\n\nThe study involved hundreds of families and compared those who received the programme with those who received usual care.\n\nResearchers wanted to see whether the programme could reduce behavioural problems in young children.\n\nThe results showed that children whose parents took part in the programme had fewer behavioural difficulties.\n\nThe benefits were still visible years later.\n\nThe Healthy Start, Happy Start programme shows that early support for parents can make a lasting difference to children’s behaviour and wellbeing.",{"type":180,"sectionSettings":2104,"slides":2105},{"textAlign":87},[2106,2111,2116],{"narrowScreenImage":2107,"wideScreenImage":2109},{"url":2108,"width":186,"height":95},"healthy-happy-work-slider-mobile-1-2x.png",{"url":2110,"width":189,"height":95},"healthy-happy-work-slider-desktop-1-2x.png",{"narrowScreenImage":2112,"wideScreenImage":2114},{"url":2113,"width":186,"height":95},"healthy-happy-work-slider-mobile-2-2x.png",{"url":2115,"width":189,"height":95},"healthy-happy-work-slider-desktop-2-2x.png",{"narrowScreenImage":2117,"wideScreenImage":2119},{"url":2118,"width":186,"height":95},"healthy-happy-work-slider-mobile-3-2x.png",{"url":2120,"width":189,"height":95},"healthy-happy-work-slider-desktop-3-2x.png",{"type":124,"sectionSettings":2122,"settings":2123,"text":1115,"cards":2124},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[2125,2130,2134,2138],{"type":134,"imgPosition":89,"strapline":372,"title":373,"summary":225,"image":2126,"link":2128,"categories":2129},{"url":2127,"width":139,"height":376},"morph-work-card-recovery-2x.png",{"url":378},[50],{"type":134,"imgPosition":89,"strapline":909,"title":1316,"image":2131,"link":2132,"categories":2133,"summary":225},{"url":912,"width":139,"height":376},{"url":914},[50,55],{"type":134,"imgPosition":89,"strapline":696,"title":1379,"image":2135,"link":2136,"categories":2137},{"url":1381,"width":139,"height":376},{"url":1383},[50,55],{"type":134,"imgPosition":89,"strapline":696,"title":697,"image":2139,"categories":2140,"link":2141},{"url":699},[50,65],{"url":701},{"type":405},{"pageTitle":711,"pageDescription":711},"\u002Fwork\u002Fhealthy-start-happy-start.en",{"title":711},"work\u002Fhealthy-start-happy-start.en","loFVcxvi_eIsBwNtLnW85MrqW06y2Hx94qlDqAqsyQY",{"id":2149,"title":373,"body":78,"description":78,"extension":5,"meta":2150,"navigation":18,"path":2225,"seo":2226,"stem":2227,"__hash__":2228},"workPages\u002Fwork\u002Frecovery-trial.en.json",{"pageTitle":373,"pageMetadata":2151,"page_content":2154,"pageSocialShare":2223},{"htmlTitle":2152,"htmlDesc":2153},"RECOVERY Trial | University of Oxford | Morph","How Morph created COVID-19 patient and clinician animations for the RECOVERY Trial at the University of Oxford - delivered in under two weeks.",[2155,2162,2163,2167,2173,2177,2184,2202,2222],{"type":85,"sectionSettings":2156,"settings":2157,"title":2158,"text":2159,"strapline":372,"image":2160},{"textAlign":87},{"imgPosition":89},"# RECOVERY Trial","Randomised Evaluation of COVID-19 Therapy.",{"url":2161,"width":94,"height":95},"recovery-work-header-2x.png",{"type":353},{"type":355,"sectionSettings":2164,"textCol1":2165,"textCol2":2166},{"textAlign":87},"Launched in the early days of the pandemic, the RECOVERY Trial grew into one of the world’s largest studies.","The trial was up and running within six weeks of funding and acted as acted as a global, rapid-response team to find out which treatments actually work—and which don’t—for hospitalized COVID-19 patients. By replacing slow, traditional research methods with a smart, streamlined approach, it quickly identified life-saving, affordable drugs (like dexamethasone) and brought them to the bedside, changing standard care worldwide within weeks. With thousands of patients enrolled across NHS hospitals, the trial needed clear communication tools to support both clinical teams and patients.",{"type":97,"sectionSettings":2168,"settings":2169,"title":225,"text":2170,"image":2171},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"## Morph Solution\n\n**Morph worked with the RECOVERY team to turn complex and changing trial information into accessible, practical animations at speed.**\n\n* **Clinician Information Animation** — a focused, minimal explainer showing NHS staff exactly how to run the trial, step by step. Designed for maximum clarity, it was delivered in just a couple of weeks.\n* **Patient Information Animation** — a reassuring two-minute animation translating the detailed Patient Information Sheet into clear, plain language. Designed to support understanding at the point of care, it was presented to patients on tablets to aid informed consent.",{"url":2172,"width":323,"height":324},"recovery-work-content-2x.png",{"type":221,"sectionSettings":2174,"settings":2175,"text":2176},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> **They have really helped explain the trial to patients at a stressful time in their care and we were delighted with the thought and care that Morph put into helping us develop them. The animations that Morph provided for the RECOVERY trial were really well-received by participants and study staff alike.**\n\nProfessor Richard Haynes, University of Oxford",{"type":584,"sectionSettings":2178,"settings":2179,"video":2180,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":2181,"videoTitle":2182,"videoTranscript":2183},"692274283?h=ab511143b9","RECOVERY Trial video","The RECOVERY Trial is being carried out by the NHS and the University of Oxford and is trying to find an effective treatment for Covid-19. \n\nYou or your child are being invited to take part in the Trial, because you’ve been admitted to hospital and have proven Covid-19. \n\nWe're testing several treatments suggested by the expert panel that advises the Chief Medical Officer in England. \n\nWe don’t know if they’ll be effective, but experts think they should be tested in people of all ages. \n\nSo the treatment may, or may not, help you or your child personally...but this study should help future patients. \n\nThe side-effects of these treatments are mostly known from other uses, so your doctor will know what to look out for and can discuss this with you. \n\nYou can also find more details in the full information sheet that you have been given. \n\nIf you or your child join the study, we will need a signed consent form and some general health information. \n\nThen you’ll be randomly allocated to one or more of the treatment options by a computer. \n\nYou will either receive the usual standard of care that all patients receive, with no additional treatment. Or the usual standard of care plus one of the treatments which might be given by mouth, injection or inhalation. \n\nNeither you nor your doctor can choose which treatment you’ll receive. But patients will only be included if their doctor thinks they are suitable. \n\nDuring the trial we will record patient health information which will be stored confidentially and securely on computers at the University of Oxford. We will get this information from your medical records. \n\nWhen you leave the hospital there will be no further visits for the trial, but we will continue to collect your medical data held by the NHS for up to ten years. \n\nJoining the study is voluntary and you or your doctor can stop the treatment at any time. \n\nIf you want any more information about the RECOVERY Trial please talk to one of the Hospital Medical Team. \n\nWe will be happy to answer your questions. \n\nThank you for considering this trial.",{"type":180,"sectionSettings":2185,"slides":2186},{"textAlign":87},[2187,2192,2197],{"narrowScreenImage":2188,"wideScreenImage":2190},{"url":2189,"width":186,"height":95},"recovery-work-slider-mobile-1-2x.png",{"url":2191,"width":189,"height":95},"recovery-work-slider-desktop-1-2x.png",{"narrowScreenImage":2193,"wideScreenImage":2195},{"url":2194,"width":186,"height":95},"recovery-work-slider-mobile-2-2x.png",{"url":2196,"width":189,"height":95},"recovery-work-slider-desktop-2-2x.png",{"narrowScreenImage":2198,"wideScreenImage":2200},{"url":2199,"width":186,"height":95},"recovery-work-slider-mobile-3-2x.png",{"url":2201,"width":189,"height":95},"recovery-work-slider-desktop-3-2x.png",{"type":124,"sectionSettings":2203,"settings":2204,"text":1115,"cards":2205},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[2206,2210,2214,2218],{"type":134,"imgPosition":89,"strapline":397,"title":711,"image":2207,"link":2208,"categories":2209},{"url":400},{"url":402},[50,65],{"type":134,"imgPosition":89,"strapline":909,"title":1316,"image":2211,"link":2212,"categories":2213,"summary":225},{"url":912,"width":139,"height":376},{"url":914},[50,55],{"type":134,"imgPosition":89,"strapline":696,"title":1379,"image":2215,"link":2216,"categories":2217},{"url":1381,"width":139,"height":376},{"url":1383},[50,55],{"type":134,"imgPosition":89,"strapline":696,"title":697,"image":2219,"categories":2220,"link":2221},{"url":699},[50,65],{"url":701},{"type":405},{"pageTitle":2224,"pageDescription":2224},"Morph work - RECOVERY Trial","\u002Fwork\u002Frecovery-trial.en",{"title":373},"work\u002Frecovery-trial.en","IpnV7eN3qsD9xiiHy-_n_cEFCmnhk5ub_iehI7kGegw",{"id":2230,"title":2231,"body":78,"description":78,"extension":5,"meta":2232,"navigation":18,"path":2307,"seo":2308,"stem":2309,"__hash__":2310},"workPages\u002Fwork\u002Fscience-trial.en.json","SCIENCE Study",{"pageTitle":2231,"pageMetadata":2233,"page_content":2236,"pageSocialShare":2305},{"htmlTitle":2234,"htmlDesc":2235},"SCIENCE Trial | Childhood Elbow Fractures | Morph","A full communication package for the SCIENCE surgical trial - patient animation, digital PIS, study website, and dissemination materials in five languages.",[2237,2244,2245,2249,2255,2259,2266,2284,2304],{"type":85,"sectionSettings":2238,"settings":2239,"title":2240,"text":2241,"strapline":372,"image":2242},{"textAlign":87},{"imgPosition":89},"# SCIENCE Study","Surgical fixation versus non-surgical care for children with a displaced medial epicondyle fracture of the elbow (the SCIENCE study)",{"url":2243,"width":94,"height":95},"science-work-header-2x.png",{"type":353},{"type":355,"sectionSettings":2246,"textCol1":2247,"textCol2":2248},{"textAlign":87},"The SCIENCE Study compared surgical and non-surgical treatment for childhood elbow fractures.","Published in *The Lancet*, the SCIENCE study is the largest multi-centre randomised controlled trial of its kind. The trial included 334 children aged 7 to 15 years across hospitals in the UK, Australia, and New Zealand. Researchers in Liverpool and Oxford found that surgery for a common elbow fracture in children offers no clinical benefit compared with non-surgical care. The findings have important implications for treatment decisions and could deliver substantial cost savings to the NHS.",{"type":97,"sectionSettings":2250,"settings":2251,"title":225,"text":2252,"image":2253},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"## Morph solution\n\n**Our solution for SCIENCE supported both recruitment and dissemination, bringing together a coordinated set of digital tools across the life of the study.**\n\n* **Study Website** – a professional public-facing hub for the trial, hosting the Patient Information Animation and an online Patient Information Sheet to provide a clear and accessible route for participants.\n* **Patient Information Animation** – a 2D explainer designed to summarise the study and support understanding during recruitment.\n* **Online Patient Information Sheet** – a structured digital version of the PIS, enabling participants to review information clearly and at their own pace.\n* **Dissemination Animation** – a concise 2D explainer presenting the study’s findings in a clear and accessible format.\n* **Dissemination Website** – a dedicated online home for the study’s results and outputs, bringing together the animation, a clinical pathway PDF to support implementation, a general infographic, and a patient information leaflet.\n\nAll dissemination materials and the website were produced in English and four additional languages, with language selection controlled by the user.",{"url":2254,"width":323,"height":324},"science-work-content-2x.png",{"type":221,"sectionSettings":2256,"settings":2257,"text":2258},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> **Working with the Morph team is great - I’ve worked with them over several studies, and they understand clinical research and what a study needs to be successful. They really become part of the study team during setup, and are hugely responsive.** \n\nProfessor Dan Perry, Children's Orthopaedic Surgeon, University of Liverpool",{"type":584,"sectionSettings":2260,"settings":2261,"video":2262,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":2263,"videoTitle":2264,"videoTranscript":2265},"1106201868","SCIENCE Study Animation","A medial epicondyle fracture is a break on the inner side of the elbow where a small piece of bone gets damaged every year. Thousands of children around the world have this type of fracture.\n\nIn the past, doctors treated it in different ways. Some used a cast, allowing the bone to heal on its own. Others performed surgery, fixing the bone with screws or wires.\n\nHowever, families want to feel confident that surgery will really benefit their child before going ahead.\n\nTo find out if surgery was better than a cast, researchers carried out the SCIENCE study, short for Surgery or Cast for Injuries of the Epicondyle in Children’s Elbows.\n\nThe study involved 334 children aged 7 to 15 from the UK, Australia and New Zealand. All had a displaced medial epicondyle fracture. A quarter had a particularly severe injury where the elbow was initially dislocated.\n\nThe SCIENCE study was a randomised trial. This means each child had an equal chance of receiving either treatment. The decision was made by chance, rather than by families or doctors, to make the comparison fair and ensure the results were trustworthy.\n\nHalf of the children wore a cast for four weeks, while the other half had surgery to fix the bone with screws or wires during their recovery.\n\nChildren and families were asked about pain, how well they could use their arm, how many hospital visits they had, and how much school they missed.\n\nThe results showed that both treatments worked just as well. Surgery did not lead to better recovery. Children had similar levels of pain, used their arms in the same way, and got back to sport just as quickly.\n\nHowever, using a cast meant fewer operations, fewer complications, fewer days of school missed, and lower costs for families and the health system.\n\nSo, for children with this kind of elbow fracture, wearing a cast is just as effective as surgery and comes with fewer risks and lower costs.",{"type":180,"sectionSettings":2267,"slides":2268},{"textAlign":87},[2269,2274,2279],{"narrowScreenImage":2270,"wideScreenImage":2272},{"url":2271,"width":186,"height":95},"science-work-slider-mobile-1-2x.jpg",{"url":2273,"width":189,"height":95},"science-work-slider-desktop-1-2x.jpg",{"narrowScreenImage":2275,"wideScreenImage":2277},{"url":2276,"width":186,"height":95},"science-work-slider-mobile-2-2x.png",{"url":2278,"width":189,"height":95},"science-work-slider-desktop-2-2x.png",{"narrowScreenImage":2280,"wideScreenImage":2282},{"url":2281,"width":186,"height":95},"science-work-slider-mobile-3-2x.jpg",{"url":2283,"width":189,"height":95},"science-work-slider-desktop-3-2x.jpg",{"type":124,"sectionSettings":2285,"settings":2286,"text":1115,"cards":2287},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[2288,2292,2296,2300],{"type":134,"imgPosition":89,"strapline":372,"title":849,"image":2289,"link":2290,"categories":2291},{"url":851,"width":139,"height":376},{"url":772},[60],{"type":134,"imgPosition":89,"strapline":381,"title":382,"image":2293,"link":2294,"categories":2295,"summary":225},{"url":384,"width":139,"height":376},{"url":386},[50,60,55],{"type":134,"imgPosition":89,"strapline":389,"title":390,"image":2297,"link":2298,"categories":2299},{"url":392,"width":139,"height":376},{"url":394},[55,50,60],{"type":134,"imgPosition":89,"strapline":1130,"title":1021,"image":2301,"link":2302,"categories":2303},{"url":1023},{"url":1025},[50,60,55],{"type":405},{"pageTitle":2306,"pageDescription":2306},"Morph work - SCIENCE Study","\u002Fwork\u002Fscience-trial.en",{"title":2231},"work\u002Fscience-trial.en","UYBt1d6M87mLqtqoyvLrkRzMOJEHTabTHYpaMzhOt98",{"id":2312,"title":1803,"body":78,"description":78,"extension":5,"meta":2313,"navigation":18,"path":2398,"seo":2399,"stem":2400,"__hash__":2401},"workPages\u002Fwork\u002Fsurge-study.en.json",{"pageTitle":1803,"pageMetadata":2314,"page_content":2317,"pageSocialShare":2397},{"htmlTitle":2315,"htmlDesc":2316},"SURGE Study | NHS Urgent Care Research | Morph","Morph produced an explainer animation and a study website for the SURGE study into workforce challenges in urgent care at the University of the West of England.",[2318,2325,2331,2335,2341,2345,2352,2356,2374,2396],{"type":85,"sectionSettings":2319,"settings":2320,"title":2321,"text":2322,"strapline":1496,"image":2323},{"textAlign":87},{"imgPosition":89},"# SURGE Study","Same day and urgent care workforce research partnership.",{"url":2324,"width":94,"height":95},"surge-work-header-2x.png",{"type":1059,"sectionSettings":2326,"maxLogosPerRow":129,"logos":2327},{"textAlign":87,"sectionLabel":1061},[2328,2329,2330],{"url":1064,"alt":381},{"url":1066,"alt":1067},{"url":1069,"alt":1070},{"type":355,"sectionSettings":2332,"textCol1":2333,"textCol2":2334},{"textAlign":87},"The SURGE Study is investigating workforce challenges across the NHS same day and urgent care system.","Same day and urgent care is delivered by a wide range of healthcare professionals working in busy and unpredictable environments. These pressures can affect staff wellbeing, recruitment and retention, and ultimately the quality of patient care. \n\nThe SURGE Study brings together clinicians, researchers, service planners, patients and the public to understand workforce challenges across urgent care services. Over five years, it will develop evidence to support a stronger and more sustainable workforce.",{"type":97,"sectionSettings":2336,"settings":2337,"title":225,"text":2338,"image":2339},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"### Morph solution\n\n**Morph worked with the SURGE team to develop a bespoke digital communication platform to support the study over several years. Unlike a traditional clinical trial site, the SURGE website was designed as a long-term hub to bring together multiple workstreams and research outputs as the study evolves.**\n\n* **Explainer Animation** – a clear, engaging animation introducing the SURGE study and explaining its aims. The animation provides a simple overview of the workforce challenges being explored and helps audiences quickly understand the purpose and scope of the research.\n* **Study Website** – a bespoke website designed as the central hub for SURGE. The site introduces the study, its partners and research areas, and will expand over time to host outputs from different workstreams. Designed to be clear and accessible, it provides a flexible structure that can grow alongside the study as new research and findings are published.",{"url":2340,"width":323,"height":324},"surge-work-content-2x.png",{"type":221,"sectionSettings":2342,"settings":2343,"text":2344},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> **It has been an absolute pleasure to work with morph on the design of our study website. They took the time to really understand what we needed from the site both now, and as our research progresses. The design is both visually impactful and very user-friendly; we are particularly impressed with the excellent animations that really bring the work to life.**\n\nProfessor Nicola Walsh, University of the West of England",{"type":584,"sectionSettings":2346,"settings":2347,"video":2348,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":2349,"videoTitle":2350,"videoTranscript":2351},"1107857523?h=1298e8f5fb","SURGE Study Animation","Same day and urgent care is delivered by a diverse range of healthcare professionals. \n\nThe work is time critical, high pressure, and unpredictable, making the workforce vulnerable to poorer mental and physical health and reduced wellbeing. \n\nThis affects sickness levels, job satisfaction, performance, and ultimately the quality of patient care.\n\nStaff recruitment and retention are among the most difficult in the NHS, creating challenges in providing timely and safe care to patients when they need it most.\n\nThe same day, and urgent care workforce research partnership, or surge brings together clinical and academic partners, service planners, patients, and the public to identify key challenges in ambulance services, primary care, emergency departments, and urgent community response.\n\nOver five years, we'll co-design research to tackle the most pressing workforce issues, ranging from national evaluations to rapid reviews and scoping studies using real world evidence.\n\nWe aim to support the wellbeing, development, and retention of the same day and urgent care workforce, improving experiences for staff and patients.\n\nThe surge partnership will provide impactful, rapidly transferable evidence to help employers build a stronger, more sustainable workforce.",{"type":221,"sectionSettings":2353,"settings":2354,"text":2355},{"textAlign":126,"sectionLabel":678,"theme":1528},{"btnTheme":102,"stackBtns":103},"> **The final result is a website that has a distinctive brand and operates without any technical issues.We have worked with morph multiple times now, have recommended them to others and would not hesitate to partner with them again in the future.**\n\nProfessor Nicola Walsh, University of the West of England",{"type":180,"sectionSettings":2357,"slides":2358},{"textAlign":87},[2359,2364,2369],{"narrowScreenImage":2360,"wideScreenImage":2362},{"url":2361,"width":186,"height":95},"surge-work-slider-mobile-1-2x.jpg",{"url":2363,"width":189,"height":95},"surge-work-slider-desktop-1-2x.jpg",{"narrowScreenImage":2365,"wideScreenImage":2367},{"url":2366,"width":186,"height":95},"surge-work-slider-mobile-2-2x.png",{"url":2368,"width":189,"height":95},"surge-work-slider-desktop-2-2x.png",{"narrowScreenImage":2370,"wideScreenImage":2372},{"url":2371,"width":186,"height":95},"surge-work-slider-mobile-3-2x.jpg",{"url":2373,"width":189,"height":95},"surge-work-slider-desktop-3-2x.jpg",{"type":124,"sectionSettings":2375,"settings":2376,"text":1115,"cards":2377},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},[2378,2384,2388,2392],{"type":134,"imgPosition":89,"strapline":1070,"title":1740,"image":2379,"link":2381,"categories":2383},{"url":2380},"morph-work-card-dmapp-2x.png",{"url":2382},"\u002Fwork\u002Fd-mapp-study",[50],{"type":134,"imgPosition":89,"strapline":696,"title":1379,"image":2385,"link":2386,"categories":2387},{"url":1381,"width":139,"height":376},{"url":1383},[50,55],{"type":134,"imgPosition":89,"strapline":389,"title":390,"image":2389,"link":2390,"categories":2391},{"url":392,"width":139,"height":376},{"url":394},[55,50,60],{"type":134,"imgPosition":89,"strapline":381,"title":382,"image":2393,"link":2394,"categories":2395,"summary":225},{"url":384,"width":139,"height":376},{"url":386},[50,60,55],{"type":405},{"pageTitle":1803,"pageDescription":1803},"\u002Fwork\u002Fsurge-study.en",{"title":1803},"work\u002Fsurge-study.en","jhdZdJijHuGHa5IO9MYhHksmCURPmDuDmTYP-OSYeZ8",{"id":2403,"title":918,"body":78,"description":78,"extension":5,"meta":2404,"navigation":18,"path":2486,"seo":2487,"stem":2488,"__hash__":2489},"workPages\u002Fwork\u002Ftilli-study.en.json",{"pageTitle":918,"pageMetadata":2405,"page_content":2408,"pageSocialShare":2485},{"htmlTitle":2406,"htmlDesc":2407},"TILLI Study | Blood Clot Prevention Trial | Morph","Patient Information Animation and Tool in English, Romanian, Polish, and Punjabi for Queen Mary University of London's TILLI blood clot prevention trial.",[2409,2417,2423,2428,2434,2438,2445,2463,2484],{"type":85,"sectionSettings":2410,"settings":2411,"title":2412,"text":2413,"strapline":2414,"image":2415},{"textAlign":87},{"imgPosition":89},"# TILLI Study","Thromboprophylaxis in lower limb immobilisation after injury.","Queen Mary University of London",{"url":2416,"width":94,"height":95},"tilli-work-header-2x.png",{"type":1059,"sectionSettings":2418,"maxLogosPerRow":129,"logos":2419},{"textAlign":87,"sectionLabel":1061},[2420,2421,2422],{"url":1064,"alt":381},{"url":1066,"alt":1067},{"url":1069,"alt":1070},{"type":355,"sectionSettings":2424,"textCol1":2426,"textCol2":2427},{"textAlign":87,"sectionLabel":2425},"Background","The TILLI Study is investigating the best way to prevent blood clots in people with lower limb injuries.","The study compares different blood-thinning medicines to understand which approach is most clinically effective and cost-effective for patients at higher risk. Blood clots, known as venous thromboembolism, can cause serious illness and may become life-threatening if they travel to the lungs. The findings will help inform future guidance on preventing blood clots in patients with lower limb injuries.",{"type":97,"sectionSettings":2429,"settings":2430,"title":225,"text":2431,"image":2432},{"textAlign":87,"sectionLabel":1077},{"imgWidth":101,"imgPosition":89,"textPosition":87,"btnTheme":102,"stackBtns":103},"## Morph solution\n\n**Morph supported the TILLI Study with our Patient Information Solution, providing a Patient Information Animation and an interactive Patient Information Tool.**\n\n* **Patient Information Animation** – a clear, visually engaging animation explaining what taking part in the TILLI study involves. Designed to summarise the key points of the patient information, it helped participants understand the trial before reviewing the full written document.\n* **Patient Information Tool (PIT)** – an interactive digital version of the patient information sheet, allowing participants to review the information step by step in full-screen mode, with the option to switch language.\n\nBoth the animation and the tool were translated into Romanian, Polish and Punjabi, including voiceover, in-video text and subtitles, helping make the information accessible to a wider range of participants.",{"url":2433,"width":323,"height":324},"tilli-work-content-2x.png",{"type":221,"sectionSettings":2435,"settings":2436,"text":2437},{"textAlign":126,"sectionLabel":678,"theme":102},{"btnTheme":102,"stackBtns":103},"> Morph are fantastic to work with and are our go to here at Bone & Joint Health, QMUL. They bring a deep understanding of clinical research, have a clear process for collaboration and always deliver results that exceed expectations.\n\nJamila Kassam, Academic Strategic Lead,  Centre for Bone and Joint Health",{"type":584,"sectionSettings":2439,"settings":2440,"video":2441,"text":225},{"textAlign":87,"sectionLabel":1088},{"videoAlign":126},{"vimeoId":2442,"videoTitle":2443,"videoTranscript":2444},"969741246?h=43edc931cf","TiLLI Study video","If you have a lower limb injury, you may need to wear a plaster cast or a boot to support your leg while it heals.\n\nWhile your leg is immobilised, the blood in your veins may not flow as well as usual.\n\nThis can increase the risk of developing a blood clot.\n\nBlood clots that form in the veins are known as venous thromboembolism, or VTE.\n\nA blood clot can cause swelling and pain in the leg.\n\nIn some cases, a clot can travel to the lungs.\n\nThis is called a pulmonary embolism and can be life-threatening.\n\nDoctors sometimes prescribe blood-thinning medicines to reduce the risk of clots forming.\n\nHowever, these medicines can also increase the risk of bleeding.\n\nThe TILLI Study is looking at the best way to prevent blood clots in people with lower limb injuries who may be at risk.\n\nThe study is comparing different blood-thinning medicines to understand which treatment works best and is most cost-effective.\n\nIf you decide to take part, you will be asked to sign a consent form.\n\nYou will also be asked to complete some short questionnaires about your health.\n\nYour treatment will be decided randomly by a computer.\n\nThis means that neither you nor your doctor will choose which treatment you receive.\n\nDuring the study, we will follow up with you to see how you are recovering.\n\nTaking part is voluntary and you can leave the study at any time.\n\nThe results of this study will help doctors understand how best to prevent blood clots in people with lower limb injuries in the future.",{"type":180,"sectionSettings":2446,"slides":2447},{"textAlign":87},[2448,2453,2458],{"narrowScreenImage":2449,"wideScreenImage":2451},{"url":2450,"width":186,"height":95},"tilli-work-slider-mobile-1-2x.png",{"url":2452,"width":189,"height":95},"tilli-work-slider-desktop-1-2x.png",{"narrowScreenImage":2454,"wideScreenImage":2456},{"url":2455,"width":186,"height":95},"tilli-work-slider-mobile-2-2x.png",{"url":2457,"width":189,"height":95},"tilli-work-slider-desktop-2-2x.png",{"narrowScreenImage":2459,"wideScreenImage":2461},{"url":2460,"width":186,"height":95},"tilli-work-slider-mobile-3-2x.jpg",{"url":2462,"width":189,"height":95},"tilli-work-slider-desktop-3-2x.jpg",{"type":124,"sectionSettings":2464,"settings":2465,"text":2466,"cards":2467},{"textAlign":126,"sectionLabel":366,"customClass":367},{"alignCardContent":87,"showAllOnLoad":33,"categoriseWhenShowAll":33,"wholeClickable":18,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":33,"headerFontSize":129,"themeWholeCard":18,"alignCards":126},"## Similar work",[2468,2472,2476,2480],{"type":134,"imgPosition":89,"strapline":696,"title":1379,"image":2469,"link":2470,"categories":2471},{"url":1381,"width":139,"height":376},{"url":1383},[50,55],{"type":134,"imgPosition":89,"strapline":909,"title":1316,"image":2473,"link":2474,"categories":2475,"summary":225},{"url":912,"width":139,"height":376},{"url":914},[50,55],{"type":134,"imgPosition":89,"strapline":1130,"title":1021,"image":2477,"link":2478,"categories":2479},{"url":1023},{"url":1025},[50,60,55],{"type":134,"imgPosition":89,"strapline":381,"title":382,"image":2481,"link":2482,"categories":2483,"summary":225},{"url":384,"width":139,"height":376},{"url":386},[50,60,55],{"type":405},{"pageTitle":918,"pageDescription":918},"\u002Fwork\u002Ftilli-study.en",{"title":918},"work\u002Ftilli-study.en","DhVddAtGTRRgtWkpnxYHWlE5G0NkXF0zZhKtmybmyNY",{"id":2491,"title":2492,"body":78,"description":78,"extension":5,"meta":2493,"navigation":18,"path":2587,"seo":2588,"stem":2589,"__hash__":2590},"workPages\u002Fwork\u002Findex.en.json","Work homepage",{"pageTitle":24,"pageMetadata":2494,"page_content":2497,"pageSocialShare":2585},{"htmlTitle":2495,"htmlDesc":2496},"Our Work | Clinical Trial Communication Projects | Morph","Explore Morph's portfolio of clinical trial communication projects - animations, patient information tools, and study websites for research institutions.",[2498,2505,2584],{"type":85,"sectionSettings":2499,"settings":2500,"title":2501,"text":2502,"image":2503},{"textAlign":87},{"imgPosition":89},"# Work","Here is a selection of our latest projects.",{"url":2504,"width":94,"height":95},"header-package-box-2x.png",{"type":124,"sectionSettings":2506,"settings":2508,"text":225,"cards":2517},{"textAlign":126,"sectionLabel":2507,"customClass":367},"Work cards",{"alignCardContent":87,"showAllOnLoad":18,"categoriseWhenShowAll":33,"wholeClickable":18,"cardCategories":2509,"headerLevel":129,"cardTheme":102,"numberedCards":33,"maxCardsPerRow":130,"isFilterable":18,"headerFontSize":130,"themeWholeCard":18,"alignCards":126},[2510,2511,2512,2513,2514,2515],{"title":50},{"title":55},{"title":60},{"title":65},{"title":70},{"title":2516},"Bespoke",[2518,2522,2526,2530,2534,2538,2544,2548,2552,2556,2560,2564,2568,2572,2576,2580],{"type":134,"imgPosition":89,"strapline":372,"title":373,"summary":225,"image":2519,"link":2520,"categories":2521},{"url":2127,"width":139,"height":376},{"url":378},[50],{"type":134,"imgPosition":89,"strapline":381,"title":382,"image":2523,"link":2524,"categories":2525,"summary":225},{"url":384,"width":139,"height":376},{"url":386},[50,60,55,2516],{"type":134,"imgPosition":89,"strapline":372,"title":689,"image":2527,"link":2528,"categories":2529},{"url":691,"width":139,"height":376},{"url":693},[50,65],{"type":134,"imgPosition":89,"strapline":696,"title":1379,"image":2531,"link":2532,"categories":2533},{"url":1381,"width":139,"height":376},{"url":1383},[50,55,2516],{"type":134,"imgPosition":89,"strapline":372,"title":849,"image":2535,"link":2536,"categories":2537},{"url":851,"width":139,"height":376},{"url":772},[60,65,70,50,55],{"type":134,"imgPosition":89,"strapline":381,"title":1142,"image":2539,"link":2541,"categories":2543},{"url":2540,"width":139,"height":376},"morph-work-card-adepp-2x.png",{"url":2542},"\u002Fwork\u002Fadepp-study",[50,55,60],{"type":134,"imgPosition":89,"strapline":909,"title":1316,"image":2545,"link":2546,"categories":2547,"summary":225},{"url":912,"width":139,"height":376},{"url":914},[50,55],{"type":134,"imgPosition":89,"strapline":696,"title":697,"image":2549,"categories":2550,"link":2551},{"url":699},[50,65],{"url":701},{"type":134,"imgPosition":89,"strapline":372,"title":704,"image":2553,"link":2554,"categories":2555},{"url":845,"width":139,"height":376},{"url":708},[70,65,60,55,50],{"type":134,"imgPosition":89,"strapline":389,"title":390,"image":2557,"link":2558,"categories":2559},{"url":392,"width":139,"height":376},{"url":394},[55,50,60,2516],{"type":134,"imgPosition":89,"strapline":917,"title":918,"image":2561,"link":2562,"categories":2563,"summary":225},{"url":920,"width":139,"height":376},{"url":922},[50,55],{"type":134,"imgPosition":89,"strapline":1070,"title":1740,"image":2565,"link":2566,"categories":2567},{"url":2380},{"url":2382},[50,2516],{"type":134,"imgPosition":89,"strapline":372,"title":929,"image":2569,"link":2570,"categories":2571},{"url":931,"width":139,"height":376},{"url":933},[50,60,55],{"type":134,"imgPosition":89,"strapline":1130,"title":1021,"image":2573,"link":2574,"categories":2575},{"url":1023},{"url":1025},[50,60,55],{"type":134,"imgPosition":89,"strapline":696,"title":1803,"image":2577,"link":2578,"categories":2579},{"url":1805,"width":139,"height":376},{"url":1807},[60,50,2516],{"type":134,"imgPosition":89,"strapline":397,"title":711,"image":2581,"link":2582,"categories":2583},{"url":400},{"url":402},[50,65],{"type":405},{"pageTitle":2586,"pageDescription":24},"Work ","\u002Fwork\u002Findex.en",{"title":2492},"work\u002Findex.en","r8fwFvMeWgZo_VDs53DUZjQmESohWhfUwMTyl4UFAG8",1780493772769]